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Abstract: The purpose of the study reported within this thesis was to fabricate 
multicomponent gel beads consisting of the polymer gel calcium alginate and the 
supramolecular gel DBS-CONHNH2. This study built upon previous work in the Smith group 
wherein beads on the micrometre scale had been fabricated. Here, nano-scale beads are 
fabricated and reported. In order to achieve this, multiple combinations of parameters 
were tested in the same general method in order to further understand how each 
parameter (temperature, oil phase, pH, volume, etc.) affects the size of the beads achieved. 
Under certain parameters, beads below the upper injectable limit of 200 nm were 
produced, a significant step which opens up the possibility for biomedical applications of 
these beads. The beads were analysed via dynamic light scattering (DLS) and electron 
microscopy in order to attain measurements for size, whilst infrared spectroscopy (IR) and 
nuclear magnetic resonance (NMR) were used to ascertain composition and yield. 
Following the downsizing of these beads, magnetic iron oxide nanoparticles were 
introduced to the procedure with the aim of fabricating beads which will exhibit attraction 
to an applied magnetic field. By introducing this property, it is hoped that directed drug 
delivery may be possible in the future, with beads being administered intravenously and 
subsequently being directed to a target site under the influence of an applied magnetic 
field. Additional work was also conducted to investigate the effect of metal salts – 
specifically ferric and cupric chloride – on DBS-CONHNH2. The formation of nanoparticles 
was observed under electron microscopy, with some iron oxide species being formed in the 
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1.1. An introduction to gels 
Gels are commonplace in everyday life, from shampoos and shower gels to contact lenses 
and thermal pastes, this class of materials is perhaps the most used in modern life. In 
chemistry, a gel may be defined as a colloidal ‘solid-like’ system which contains solvent in its 
pores as a ‘liquid-like’ phase. This ‘liquid-like’ phase may be water in the case of hydrogels,1 
organic solvent in organogels,2 or air in xerogels/aerogels.3 In hydrogels, hydrophilic groups 
enable the absorption and entrapment of water (see Figure 1), swelling the gel until it 
contains up to 99% water by weight. Gels may be produced naturally by both plants and 
animals, such as aloe gel produced by the aloe vera plant, mucus secreted by mucous glands, 
or the cartilage found in a majority of fauna. Alternatively, they may be produced synthetically 
from a wide range of starting molecules. This class of materials is ubiquitous, spanning areas 
such as pharmaceuticals,4 cosmetics, electronics,5 and the food industry.6 Gels are formed 
through a process termed ‘gelation’, which may occur through the formation of chemical 
bonds (polymer gel) or through self-assembly driven by supramolecular interactions. 
Typically, polymer gels are produced from gelators with higher molecular weight, whereas 
supramolecular gels are typically formed from low molecular weight gelators (LMWGs). 
Polymer gels, owing to the nature of intermolecular interactions, are usually stiffer and less 
affected by external stimuli than their supramolecular counterparts. 
 
 
Figure 1: Diagram of the structure of a gel (green) with solvent (blue) entrapped in its pores. 
Historically, naturally occurring hydrogels may have been used pharmaceutically by humans 
since at least 1550 BC, when medicinal uses for aloe vera were described in the Ebers Papyrus. 
Scientifically, hydrogels were described by Bemmelen7 in 1896, where this specific term was 
first used to describe a colloidal gel formed by inorganic salts. This field of research was largely 
neglected until Wichterle and Lim8 published their 1960 paper describing soft contact lenses 
formed from the hydrogel poly(2-hydroxyethyl methacrylate). Following this, a growth in 
interest around these materials was observed although routes of exploration were mainly 
focussed on ophthalmological applications. For example, Refojo et al.9 explored the use of 
dehydrated glyceryl methacrylate as a possible vitreous implant to improve the outcome of 
cases of retinal detachment. It was not until 1982 that hydrogels were suggested as drug 
delivery vehicles, when Mueller et al.10 described the uptake and controlled release of water-
soluble drugs by poly(2-hydroxyethyl methacrylate) gel beads. This was followed by a marked 
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boom in research into hydrogels as drug delivery vehicles, with a vast array of gelators being 
explored, both polymeric and supramolecular in nature. 
 
Polymeric gels are typically stiffer than supramolecular gels, owing to the covalent or ionic 
bonding present between gelator molecules. In addition, these gels tend to be unresponsive 
to external stimuli such as changes in temperature or pH.11 Polymer gels are usually formed 
from the gelation of higher molecular weight gelators (see Figure 2), such as poly(vinyl 
alcohol) (PVA),12 cellulose,13 or poly(ethylene glycol) (PEG),14 and are broadly non-toxic and 
biocompatible, thus lending themselves to biological applications. Poly(ethylene glycol), 
although not always a gel, was first proposed for use in drug delivery systems by Yoshida et 
al.15 when they used delivery vehicles containing PEG for testosterone transport in rats. It was 
shown that the presence of PEG increased testosterone levels in the rats at a level 3.2 times 
greater than in the absence of PEG.   Senior et al.16 further explored the efficacy of PEG for 
drug delivery, and it was found that PEG-coated liposomes were cleared from blood 
circulation at a rate 30% slower than liposomes without a PEG coating, suggesting that the 
use of PEG would aid sustained drug release. This strategy of adding PEG to drug delivery 
vehicles has since become known as PEGylation,17 and is a widely employed strategy for 
improving drug delivery efficacy. In general, the combination of different polymer gels in one 
composite gel has become more common as a method to combine properties of two or more 
gels.18 PVA, for example, has been combined with chitosan and cellulose by Fan et al.19 to 
improve the wound healing properties of PVA by imparting the antiseptic properties of 
chitosan. Alternatively, polymer gels have also been combined with supramolecular gels in 
order to combine the properties of both of these classes of gel. 
 
 
Figure 2: Structures of three different polymer gelators. 
Supramolecular gels were first described in 1841,20 though they were mostly ignored in an 
academic setting until 1997, when Terech and Weiss21 published a landmark review on 
supramolecular organogels and their unique properties. These gels are primarily formed 
through non-covalent interactions such as van der Waals forces, hydrogen bonding, or 𝜋-𝜋 
stacking between monomeric units.22 N,N’-dibenzoyl-L-cystine, for example, self-assembles 
through  𝜋-𝜋 stacking interactions between aromatic rings and hydrogen bonding between 
amide and carboxyl groups.23 Owing to the inherent weakness and reversibility of these 
individual forces, supramolecular gels are likely to be less stiff than polymeric gels formed 
through covalent or ionic bonding. However, these gels are commonly responsive to external 
stimuli, exhibiting reversible thermally- or pH-triggered gelation.24 It should be noted that 
stimuli responsiveness may still be present in chemically linked polymer gels, such as poly(N-
isopropylacrylamide) (PNIPAAm),25 but this mainly affects the swelling behaviour in these 
chemically crosslinked gels and typically does not reverse the gelation as in supramolecular 
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gels are also being explored for biomedical applications. Supramolecular gelators derived 
from natural materials, such as N,N’-dibenzoyl-L-cystine, have been explored for drug release 
by Friggeri et al.,26 who reported that the rate of drug release may be dependent on the 
strength of the interactions between drug and gelator. This observation was key in the 
development of supramolecular gels as it provided evidence that different gels could be 
designed to improve control over drug release in vivo. Gelator molecules have since been 
designed with tailored groups for the control of drug release. Supramolecular hydrogelators 
based on amino acids,27 carbohydrates,28 and nucleosides29 have all been synthesised (see 
Figure 3), resulting in the formation of one of the most diverse and versatile classes of 




Figure 3: (Upper) Examples of supramolecular gelators. (Lower) Schematic diagram of self-assembly from single molecules 
to fibrils to gel network. 
Evidently, gels as a class of material are vast. They are composed of myriad different 
compounds, each with different physiochemical properties. Many of these gels are non-toxic, 
biocompatible, and produced through simple synthetic steps. As a consequence of their 
properties, they have become widely employed across many different sectors and have 
shown great promise in the field of biomedicine. The importance of gels cannot, therefore, 
be understated. 
 
1.2 Alginate gels and drug delivery 
Naturally sourced polymer gels may be recovered from a multitude of biota, for example 
cellulose and agarose may both be isolated from the cell walls of green plants and red 

































polysaccharide which is abundant in marine crustaceans such as shrimp and crabs.32 These 
natural polymers, beyond being so common, are biocompatible and non-toxic as a result of 
their biotic origin. These attributes open up potential applications in pharmaceuticals and 
medicinal chemistry, with gelators such as chitosan possessing antimicrobial properties as a 
result of its primary amino groups.33 One natural hydrogelator which has emerged as a 
popular option is calcium alginate, the calcium salt of alginic acid. 
 
Alginic acid is a hydrophilic linear polysaccharide which naturally occurs in some bacteria and 
the walls of brown seaweed, accounting for up to 40 % w/w dry weight of some seaweed 
species.34 When hydrated, alginic acid forms a viscous fluid which is responsible for the rigidity 
of the seaweed. Commercially, this product has found use as a stabiliser in items such as ice 
creams, preserves, and marshmallows.35 This compound is a copolymer consisting of 
repeating units of 𝛽-D-mannuronate (M) and 𝛼-L-guluronate (G), forming either 
heterogenous MM or GG blocks, or heterogenous MG units (see Figure 4).36 Metal salts of 
alginic acid, such as sodium alginate, are able to form hydrogels in water upon the 
introduction of a divalent cation such as Ca2+ (with the exception of Mg2+). Gelation occurs 
through coordination about the Ca2+ cation by the G units, which propagates along the 
polymer to form a gel via lateral association of polymeric units, resulting in what is termed 
the ‘egg-box’ model.37 As this gelation occurs purely through the G units of alginate, the G:M 
ratio determines the stiffness of the hydrogel: a greater G content will result in a stiffer gel. 
The use of mannuronan C-5 epimerases allows for the design of alginate polymers with 
desired levels of G through the enzyme-facilitated conversion of M units.38 Furthermore, 
alginates high in heterogenous blocks (MG units) are water soluble at low pH, whereas highly 
homogenous alginates (MM or GG units) are insoluble in the same conditions.39 
 
 
Figure 4: Structure of alginic acid showing both M and G units (left), egg-box gelation model (right). 
The biosynthesis of alginic acid in brown algae (see Figure 5) was first investigated by Lin and 
Hassid.40 A series of enzymic activities were discovered in Fucus Gardneri Silva which are 
necessary for the synthesis of mannuronan. A biosynthetic pathway was proposed starting 
with 𝛼-D-mannose-1-phosphate which is then converted to guanosine diphosphate (GDP)-D-
mannose by the enzyme guanylyltransferase. The enzymatic activity of GDP-D-mannose 
dehydrogenase then converts this compound to GDP-D-mannuronic acid. The phosphate 
groups are then removed by glucosyl transferase to yield mannuronan, which is then 
acetylated and subsequently epimerised by acetyl transferase and C-5-epimerase 
respectively to yield alginic acid. This pathway has also been observed in Azotobacter 
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Figure 5: Biosynthetic route for mannuronan acetate. This compound is then epimerised by C-5-epimerase to form 
Guluronan acetate and subsequently alginic acid. 
There are disadvantages associated with alginate being a naturally occurring polymer. The 
main disadvantage is the presence of unwanted impurities such as polyphenols, which may 
affect the overall biocompatibility of the gels. This was shown in part by Torres et al.,42 who 
reported that cell proliferation by purified alginates is greater than that by untreated 
alginates. The implication of this is that the impurities naturally found within alginates do 
have an impact on the health of cells and should ideally be removed prior to any biomedical 
application. 
 
Biological applications for alginate gels have been proposed since at least 1950, when Slavin43 
described the use of calcium alginate as an ‘antigen depot’ for the slow release of antigens in 
rabbits, stimulating the prolonged production of antibodies and eliminating the need for 
repeated antigen injections. After this report, however, calcium alginate was – like most gels 
– largely ignored. This was in part due to Slavin’s observation that the gel was not injectable 
and required gelation in vivo via intraperitoneal injection of sodium alginate and calcium 
chloride. For the following two decades, calcium alginate was mostly used for the 
immobilisation and study of cells, having suitable physiochemical properties for this 
application, as reported by Kierstan and Bucke44, and Cheetham et al.45 In terms of biomedical 
applications, alginate gel was generally investigated as a wound dressing for cutaneous 
administration. Gilchrist et al.46 reported that Sorbsan, an alginate dressing, is effective as a 
haemostatic and at mitigating microbial infection. This haemostatic property arises from ion 
exchange between calcium alginate and free sodium in the fluid from the wound. The 
































































alginate dressings loaded with antibiotics for the sterilisation of pharmaceutical packaging, 
reporting significant antimicrobial effects of drug-loaded alginate film. 
 
It was not until 1985 that calcium alginate was proposed as a drug delivery system, when 
Badwan et al.48 reported the uptake and release of the antibiotic sulfamethoxazole by calcium 
alginate beads (see Figure 6). This bead formulation had the potential to overcome the 
problems encountered with alginate as an injectable system. By forming discrete beads, the 
overall size of the gel is reduced, while the physiochemical characteristics are retained. The 
beads formed in this study were 1.25 mm in diameter, which is too large for injection, but 
was a marked improvement on the first report of alginate beads by Seely et al.49 where beads 
4 mm in diameter were formed. The method for bead formation generally followed the same 
basic principle wherein sodium alginate solution is added dropwise to a solution of calcium 
chloride, forming beads upon contact. 
 
 
Figure 6: SEM image of the alginate bead formulated by Badwan et al. Image reproduced from Ref. 48. 
The advent of alginate beads as potential drug delivery systems did not, however, result in an 
immediate inundation of injectable alginate formulations. For the most part, alginate was 
used in oral dosage forms, such as a binder or dispersant in tablets.50 Oral administration 
does, of course, have its advantages such as increased stability of formulations, with tablets 
being more stable than injectable suspensions, and improved patient willingness.51 
Furthermore, using alginate beads these beads introduces buoyancy to the formulation, 
improving drug release in the stomach, mitigating issues with poor bioavailability at other 
areas of the digestive tract. Nakamura et al,.52 for example, loaded calcium alginate gel beads 
with theophylline, a phosphodiesterase inhibitor, for possible oral administration. The use of 
alginate beads for oral drug delivery may also aid in the pharmacokinetics of drugs, with 
Murata et al.53 reporting prolonged delivery of the antibiotic metronidazole and improved 
gastroretention times, suggesting that the use of these beads will aid in improving drug 
efficacy. Calcium alginate gel was also used as a coating for amiprilose hydrochloride tablets 
by Kaneko et al.54 and found to mask the unpleasant taste of this drug, improving the oral 
administration process. Other drugs which have been combined with alginate for improved 
oral delivery include insulin,55 indomethacin,56 and irinotecan.57 Probiotics have also been 
encapsulated within alginate beads for oral administration, with improvements in viability 
observed as the bacteria are protected from the acidic pH of the stomach and the saline 
conditions of the intestine. Mandal et al.,58 for example, reported the improved survival of 
Lactobacillus casei when encapsulated in alginate beads. A more commercial application of 
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oral formulations of alginate is the antacid Gaviscon.59 Here, calcium carbonate and sodium 
alginate are utilised synergistically, with the carbonate neutralising stomach acid before 
alginate forms a gel by binding to the calcium. 
 
Evidently, calcium alginate gel is a popular option for oral administration of drugs given the 
multitude of active pharmaceutical ingredients (APIs) which have been incorporated into the 
gel. The results are largely positive, with improved drug release profiles and efficacy being 
observed. Similar results were observed with probiotics, including bolstered survival rates of 
the bacteria. Once oral formulations began to rise in popularity, consideration was given to 
achieving alginate drug delivery vehicles which are suitable for subcutaneous and intravenous 
administration. Delivering drugs to a target site via the bloodstream is arguably much more 
efficient than other routes of administration, bypassing the gastrointestinal tract entirely and 
minimising drug degradation. However, there may be considerable off-target effects when 
drugs are administered intravenously and, especially in the case of severely cytotoxic 
anticancer agents, this can result in serious side effects such as hypertension and 
cardiotoxicity.60 These off-target effects are a result of the pharmacokinetics of drugs in the 
bloodstream – they diffuse throughout the body rather than congregate at a target site. This 
also results in reduced efficacy and subsequently poor attrition rates with only 11% of novel 
drug molecules receiving regulatory approval.61  
 
By encapsulating drugs within nanoparticle vehicles, their circulation time can be increased, 
an observation in line with what is seen via oral administration. This effect, however, is of 
particular importance in the case of intravenous administration. A landmark paper by Maeda 
et al.62 described the enhanced permeability and retention (EPR) effect, in which large 
macromolecules are observed to exhibit tumouritropic behaviour and accumulate within 
solid tumours. This effect may be explained through the defective growth of tumours, 
resulting in deformities in both the cells and vascular structure, in addition to poor lymphatic 
filtration and drainage around the tumour. This means that macromolecular structures are 
not filtered out of the tumour region and may therefore accumulate. A 100% increase in drug 
delivery to a tumour site was observed in certain cases.63 The discovery of the EPR effect has, 
understandably, resulted in a swathe of research into liposomal and macromolecular drug 
delivery. However, the EPR effect may not be universally applied across all tumours, and some 
clinical trials have failed to show improved drug delivery when using a drug carrier compared 
to the free drug.64 It is believed that the animal cancer models which may be used to study 
the EPR effect are more sensitive to EPR than clinical tumours in humans. The effect is likely 
present in human tumours, but it is not functional as frequently as in animal models. The 
effect should therefore be invoked on a case-by-case basis. 
 
Calcium alginate gel is a prime candidate for intravenous drug delivery, having been shown 
to be biocompatible, non-toxic, and effective in prolonging drug release. One barrier to its 
adoption for this use, however, was the need to reduce the size of alginate beads to an 
injectable level. Typically, vehicles synthesised for injection are below 200 nm in diameter, 
such as the PEGylated liposomes developed by Najlah et al.65 for the delivery of disulfiram, or 
the poloxamer 407 liposomes reported by Paavola et al.66 for ibuprofen delivery. Efforts were 
therefore needed to improve upon the alginate bead sizes observed by simply adding sodium 
alginate solution dropwise to calcium chloride solution. Lee et al.67 reported alginate poly-L-
lysine microparticles fabricated by spraying sodium alginate solution via an air atomiser onto 
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a bath of calcium chloride solution, with a size range from 80 to 130 𝜇m. The introduction of 
poly-L-lysine has been shown to be effective in further reducing the size of alginate particles, 
with Rajaonarivony et al.68 reporting the first alginate particles in the nanometre size range 
through the addition of poly-L-lysine to a calcium alginate pregel. The pregel was formed by 
use of sodium alginate and calcium chloride concentrations below that required for gel 
formation. The beads in this case were reported to be as small as 250 nm. However, poly-L-
lysine is unsuitable for biomedical application due to its toxicity and should therefore be 
avoided. Other methods of bead size reduction should be sought. Chitosan has been explored 
as a replacement for this molecule by Robinson et al.,69 but this produced larger spheres of 
around 567 nm in diameter. A modification of this method was reported by Zahoor et al.70 to 
produce alginate nanoparticles of 236 nm in diameter, and intranasal administration of these 
particles owing to the mucoadhesive properties of alginate has been explored. Microfluidic 
routes have also been explored for producing alginate microgels. Zhang et al.71 used 
microfluidics to explore internal and external gelation methods to form alginate microbeads.  
 
Other methods have been created in attempts to produce alginate beads below 200 nm in 
diameter. A complexation method, wherein alginate capsules form around oil droplets in a 
solvent, was shown by Lertsutthiwong et al.72 to result in sizes as low as 263 nm. However, 
this method will likely only be useful for encapsulating lipophilic compounds, owing to the 
need of the alginate to complex around an oil droplet. In this case, the oil droplet was turmeric 
oil at a 1% w/v concentration. A layer-by-layer method was reported by Chen et al.,73 in which 
an oil-in-water emulsion is formed prior to the addition of a chitosan layer and then an 
alginate layer. The resultant particle size was 806 nm, though this was for the encapsulation 
of crystals which were 766 nm in diameter. Much more recently, a double emulsion method 
was attempted using an oil-in-water-in-oil system by Guo et al..74 In this method, an oil-in-
water emulsion containing alginate is formed, and this is then added dropwise to a second oil 
phase, forming water droplets which contain alginate nanocapsules formed around an oil 
core. The hydrogel particles here, however, were 7.73 𝜇m in diameter. This set of methods, 
therefore, can be said to have been largely unsuccessful in producing injectable alginate 
nanoparticles. 
 
Noticeable improvements were observed when Yi et al.75 reported the use of an emulsion 
method for the preparation of alginate-bovine serum albumen (BSA) nanoparticles with an 
average size of 166 ± 34 nm. The emulsion method, or more accurately the reverse emulsion 
method, has since become an immensely popular method for the fabrication of alginate 
nanoparticles below 200 nm in diameter. A reverse emulsion, otherwise called a water-in-oil 
emulsion, involves the addition of a surfactant to an oil phase (see Figure 7), followed by the 
addition of gelling components. The surfactant forms surfactant-stabilised water droplets 
within the oil which are usually in the nanometre size range, and gelation occurs inside these 
droplets, resulting in nanogels. The radius of water droplets in the oil may be estimated 








Where R is the radius, Is is the thickness of the surfactant layer, 𝜙" is volume fraction of 
water, 𝜙#$%&'(  is the volume fraction of the surfactant, 𝜙#)*(  is the volume fraction of 
surfactant which may be dissolved in oil.76 
 
 
Figure 7: Diagram of a water-in-oil emulsion. Formation and stabilisation of water droplets is facilitated by the nonionic 
surfactant. 
Pure alginate nanogels, however, are less common than hybrid gels. Alginate-chitosan 
nanoparticles are particularly successful, with You et al.77 reporting an average diameter of 
64 nm when gelling alginate around a chitosan nanodroplet core in a reverse emulsion, and 
Wang et al.78 reporting a nanogel diameter of 136 nm when using oligochitosan and alginate 
in combination. Reports do exist of pure calcium alginate nanoparticles formed via the 
reverse emulsion method. You et al.79 reported alginate nanoparticles of 80 nm in diameter 
formed when using toluene as the oil phase. While this result was promising, toluene is highly 
toxic and its possible presence in the final product was not discussed. Should any toluene be 
present in the alginate beads, they would not be suitable for the biomedical purposes 
proposed in the study. As toluene is slightly soluble in water, it is likely that there may be 
some residual toluene in the hydrogel. More recently, Machado et al.76 produced alginate 
nanoparticles with a diameter below 100 nm using decane as the oil phase. In this study, 
residual decane was suggested to be present in the final product by higher-than-expected 
integrals for terminal methyl groups in NMR spectroscopic analysis. Given the slight solubility 
of most oil phases in water, complete avoidance of this contamination may be impossible. 
Considerations should therefore be taken to mitigate the volume of oil phase in the product. 
 
1.3 Magnetic Nanoparticles and Targeted Drug Delivery in Hydrogels 
Having solved the size issue with alginate nanoparticles, intravenous drug delivery 
applications could now be developed. Several different drugs have already been shown to be 
effectively loaded into the beads and slowly released over time, with a number of these drugs 
being anticancer in nature. However, while the EPR effect increases the total portion of a dose 
which reaches a solid tumour, a median value of only 0.7% of a nanoparticle dose reaches the 
solid tumour.80 There is both the scope and necessity for improvement on this statistic. 
Increasing the efficacy of a drug against a target site will lower the required dose and this in 
turn will lower off-target effects and the overall cost of treatment. To this end, advancements 
have been made in improving the targeting of drugs to a specific site. 
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Drug targeting can either be passive, in which the formulation results in increased 
accumulation at the target site by increasing circulation time, or active, whereby drug release 
is made more specific to the target site or nanoparticles are directed towards the site. 
PEGylation is an example of passive targeting by way of its ‘stealth’ properties, which delays 
opsonisation of the nanoparticles and uptake by the mononuclear phagocytic system through 
the presence of a hydrophilic layer on the nanoparticle.81 This improves circulation time, and 
therefore increases accumulation in a solid tumour through the EPR effect. While it does not 
possess the same ‘stealth’ abilities as PEG, calcium alginate could be said to possess some 
passive targeting abilities in that it is slightly anionic, possessing a slightly negative surface 
charge.82 This is beneficial as neutral, zwitterionic, and slightly negatively charged 
nanoparticles have been shown to exhibit favourable pharmacokinetics with increased 
circulation time in the body.83 An example of active targeting would be making the 
nanoparticle responsive to stimuli such as pH. The environment around a tumour is more 
acidic than in normal tissue as a result of aerobic glycolysis caused by hypoxia in the tumour.84 
Na et al.85 fabricated pH-responsive nanoparticles from pullulan acetate and 
sulfadimethoxine loaded with doxorubicin which exhibited heightened cytotoxicity at pH 6.8 
and low cytotoxicity at pH 7.4. Calcium alginate, however, does not exhibit the ‘stealth’ 
abilities of PEG, nor is it stimuli responsive. A different strategy, therefore, is needed to 
introduce tumour-targeting properties to nanoparticles of this gel. One method which has 
been explored is the introduction of magnetic nanoparticles, a structure between 1-100 nm 
in diameter which exhibits attraction to an applied magnetic field. 
 
In general, magnetism arises from the presence of an unpaired electron. Electrons possess a 
property called spin magnetic moment, 𝜇!, a fundamental magnetic moment which arises 
from the spin of the electron. In the case of paired electrons, which must have opposite spins 
(+1/2, -1/2) as a result of the Pauli exclusion principle, these spin magnetic moments cancel 
out, and there is a net zero magnetic moment in the material. Where unpaired electrons are 
present, there is a spin magnetic moment which is not cancelled out and there is a magnetic 
moment in the material. In a ferromagnet, these magnetic moments align parallel to an 
applied magnetic field to give a bulk magnetisation. This bulk magnetisation remains in the 
material after the magnetic field is removed as remnant magnetisation, a property termed 
magnetic hysteresis. Magnetic hysteresis arises from the presence of magnetic domains in a 
magnetic material. Magnetic moments are aligned within domains, but not between them. 
The magnetic moments at the walls of these domains may be changed to align with a 
magnetic field, thus changing the size and ordering of domains, and energy input is required 
in the form of a magnetic field to reverse this effect and remove the bulk magnetisation. A 
magnetic nanoparticle, however, does not possess different magnetic domains due to its 
small size. Therefore, when an applied magnetic field is removed, magnetic hysteresis is not 
observed and there is no remnant magnetisation should the nanoparticle be of an adequately 
small diameter. Iron oxide, nanoparticles, for example, are superparamagnetic at room 
temperature below 10 nm.86 This property is termed superparamagnetism, as paramagnets 
do not exhibit magnetic hysteresis but the magnetic susceptibility, 𝜒, is greater in 
nanoparticles of ferromagnetic materials than in paramagnetic materials, and it is a vital 
concept in the biomedical uses of magnetic nanoparticles.  
 
Superparamagnetic nanoparticles may be formed from ferromagnetic materials such as iron 
oxide, cobalt, and nickel. Cobalt and nickel nanoparticles have been shown to be toxic to 
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aquatic life by Griffitt et al.87 and should therefore be avoided for biomedical use. 
Nanoparticles of iron oxide are relatively non-toxic which, in combination with good size-
control and ease of synthesis, makes them prime candidates for biomedical use. They have 
found use as contrast agents in MRI imaging for non-invasive cancer diagnosis, with Kim et 
al.88 showing that a ferrofluid formed from iron oxide nanoparticles and chitosan result in 
improved contrast in MRI compared to commercial imaging agents. Magnetic hyperthermia 
has also been explored as an application for iron oxide nanoparticles, though this remains 
experimental due to poor control over the final temperature and possible ablation of healthy 
tissue. Jin et al.89 showed that a heating effect is observed in Fe3O4 (magnetite) nanoparticles 
when they are exposed to an alternating magnetic field. Johannsen et al.90 presented the first 
clinical application of magnetic hyperthermia for the treatment of prostate cancer, finding 
that temperatures in the tumour could be raised to 48.5 ℃, more than sufficient to ablate 
tumour cells. Liao et al.91 functionalised magnetic nanoparticles with alginate gel for 
hyperthermia treatment, showing a 40% reduction in cancer cell viability after in vitro trials. 
 
It is the potential for targeted drug delivery with superparamagnetic nanoparticles which may 
draw the most attention. In principle, a liposome or nanogel may be fabricated containing 
magnetic nanoparticles, and a magnetic field may be applied to guide these formulations 
through the body and direct it toward the target site (see Figure 8).92 To give rise to movement 
from a distance, as would be the case with internal nanoparticles and an external magnet, a 




Figure 8: Schematic of targeted drug delivery using magnetic nanoparticles. Image reproduced from Ref. 91. 
Several magnetic formulations utilising hydrogels other than alginate have been developed 
for targeted drug delivery. Nerantzaki et al.94 have recently fabricated doxorubicin-loaded 
magnetic silica nanoparticles which exhibit cytotoxicity only in the presence of an applied 
magnetic field, indicating possible dual-action drug delivery with both hyperthermia and drug 
release inducing cell death within the tumour. Cell viability was reduced up to 50% in this 
study. Dual-action drug delivery may be vital in overcoming resistances which may be arise in 
tumours. Both hyperthermia and drug resistance have been observed in cancer cells.95, 96 
Combining these two therapies may increase the efficacy of treatment. Mancarella et al.97 
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formed hydrogel functionalised magnetic nanoparticles using layer-by-layer deposition of 
dextran and poly-L-lysine about a magnetite core which were loaded with curcumin. A 70% 
reduction in cell viability was observed compared to a control. This has since been built upon 
with alginate gels by Song et al.98 by formulating curcumin-loaded alginate/chitosan 
nanoparticles in a rather complex layer-by-layer method. The nanoparticles were reported to 
be up to 189 nm in diameter after the addition of 9 polymer layers, and cell viability was 
reduced by over 80% in in vitro studies. Ciofani et al.99 reported the formation of magnetic 
alginate nanoparticles through the reverse emulsion method, although these hydrogel 
nanoparticles were 401 nm in diameter. Importantly, however, internalisation of the 
nanoparticles by cells was much greater in the presence of a permanent magnet, making this 
an important proof-of-concept study showing that drug uptake by cells may be improved 
using these formulations. The reverse emulsion method was demonstrated to be effective in 
producing magnetic, drug-loaded alginate nanospheres by Chen et al..100 Here, hexane was 
used as the oil phase and the nanoparticles were shown to have a mean diameter of 185 nm 
and a circulation time of 15 days. 
 
Naturally, there are toxicity concerns around the introduction of nanoparticles to biological 
systems. As their use in biomedical applications is relatively novel, minimal data exists on 
delayed effects, though studies on acute toxicity are promising.101 Slow release of free 
nanoparticles from a hydrogel matrix may occur during circulation in the body, and there may 
be mechanism through which cytotoxicity can occur. Carbon nanoparticles have been shown 
to accelerate platelet aggregation in the bloodstream of rats, causing thrombosis.102 Mild 
toxicity of iron oxide nanoparticles has been observed in vitro in human macrophages by 
Pawelczyk et al.,103 with only 20% cell viability after 7 days of exposure. The concentration of 
iron within the cells was 34.75 pg per cell. However, much of the possible toxicity of iron oxide 
nanoparticles appears to be based upon the size of the particle. Most in vivo studies, however, 
do not report any toxicity of iron oxide nanoparticles. Yang et al.104 studied the biodistribution 
of a range of sizes of iron oxide nanoparticles (10, 20, 30, and 40 nm) and found no acute 
toxicity, though did note that smaller nanoparticles (10 nm) readily cross the blood-brain 
barrier to enter the brain. No behavioural changes were observed, suggesting brain function 
is not affected, but the study was concluded after just 7 days. Nonetheless, a majority of 
studies do not report any acute toxicity or impairment of normal function following the 
administration of iron oxide nanoparticles, suggesting they are safe for biomedical use. 
Moreover, they are likely to be far less cytotoxic than the anticancer agents being delivered 
within the formulation, and the release over time from the formulation is likely to be too low 
to cause any unwanted toxicity. Their use in combination with hydrogel formulations for 
targeted drug delivery should therefore be explored further and the promising results should 
be built upon. 
 
1.4 Dibenzylidene-D-Sorbitol (DBS)-CONHNH2 
Supramolecular hydrogelators have recently emerged as alternatives to polymer gels for drug 
delivery formulations. Supramolecular interactions are commonplace in nature, from the 
forces which allow geckos to ‘stick’ to surfaces, to the hydrogen bonding between 
nucleobases to form the double helix in DNA. Supramolecular gelators, therefore, are mostly 
derived from natural materials, making them highly biocompatible. The ability to design 
gelator molecules to specifically tailor interactions has led to the creation of a large library of 
possible gels. One route of exploration has led to the use of open-chain sugars as a backbone 
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for gelators, with D-sorbitol – a reduced form of glucose – finding wide employment in this 
field. One supramolecular gelator based on D-sorbitol which has attracted attention is 1,3:2,4-
dibenzylidene-D-sorbitol (DBS) (see Figure 9). 
 
 
Figure 9: Structure of DBS, a chiral, amphiphilic ‘butterfly’ gelator with a D-sorbitol ‘backbone’ and two benzaldehyde 
‘wings’. 
DBS is one of the earliest supramolecular gelators to be reported in literature, with 
Meunier105 first describing the synthesis and gelling properties of this compound in 1891. It is 
formed via a condensation reaction between D-sorbitol and benzaldehyde in a 1:2 molar ratio 
under acidic conditions. This molecule has found use in polyolefin plastic compositions, 
offering improved transparency.106 It is also the base gel in Rightguard deodorant gel sticks. 
However, much like a majority of hydrogels, the importance of this material was not realised 
until decades had passed since its discovery. In 1942, Wolfe et al.107 explored the structure of 
DBS, characterising the presence of a glycol group and thus narrowing down the exact 
structure to either 1,2,3,4- or 3,4,5,6- functionalised D-sorbitol. This was  built upon in 1944 
by Angyal et al.,108 who were able to isolate 2,4-monobenzylidene-D-sorbitol through 
hydrolysis of DBS with acetic acid in ethanol. The presence of this molecule after hydrolysis 
confirmed the structure of DBS as 1,3:2,4-dibenzylidene-D-sorbitol. No other isomer was 
encountered in this study. Following the confirmation of the structure, efforts began to 
functionalise either the benzaldehyde wings or the sorbitol body to produce derivatives of 
DBS. Several derivatives were described by Feng et al.109 with para-substituted phenyl groups 
functionalised by methyl-, methoxy-, cyano-, fluoro-, chloro-, or nitro- groups. Raluca et al.110 
also exhibited the synthesis of an amino- derivative through the reduction of the nitro group, 
and subsequent alkylation to form N-alkylated derivatives of DBS. More recently, 3,4-dichloro 
functionalised phenyl groups in DBS have been synthesised by Li et al.111 Smith and co-
workers112, 113 further expanded on the scope of possible DBS derivatives by first synthesising 
an ester functionalised DBS (DBS-CO2Me) , and then both a carboxylic acid functionalised DBS 
(DBS-COOH) and an acyl hydrazide functionalised DBS (DBS-CONHNH2) (see Figure 10).  
 
 









































DBS-CO2H was shown to be a pH-dependent gelator. In basic pH, the carboxyl group is 
deprotonated, increasing solvation and forming a solution. In acidic pH, the inverse of this 
process is observed whereby the carboxyl group is protonated and solvation is decreased. In 
this case, the molecule self-assembles into a gel. Conversely, DBS-CONHNH2 was found to be 
pH-independent. This observation suggested that unwanted pH responsiveness may be 
mitigated in supramolecular gels through the replacement of carboxyl groups with acyl 
hydrazides. The ability to tailor pH responsiveness in supramolecular gels is an important step 
towards broadening their applications in biological settings, as well as aiding in their adoption 
due to the ease of preparation, requiring less extreme gelation conditions.  
 
Initially, potential environmental applications of DBS-CONHNH2 were explored. In the same 
paper where the synthesis of DBS-CONHNH2 was first described, Smith and co-workers113 
reported that this gelator could selectively absorb dyes from solution depending on the pH. 
Here, the dyes methylene blue (MB), acid blue 25 (AB25), and naphthol blue black (NBB) were 
shown to be absorbed to different extents at different pH levels due to their protonation and 
subsequent differing interactions with the gel. For example, AB25 showed a dye absorption 
value of 1050 mg g-1 at pH 2, but less than 200 mg g-1 at pH 12. For MB, the highest observed 
uptake was 800 mg g-1, which is competitive with the previously reported highest uptake of 
this dye of 1000 mg g-1.114 Additionally, the dyes AB25 and NBB were shown to be desorbed 
from the gel when exposed to a basic NaOH (0.1 M) solution, indicating the potential to reuse 
the gel multiple times for continuous dye removal. 
 
The selective uptake ability of DBS-CONHNH2 has also been explored with the use of precious 
metals. Smith and co-workers115 reported the palladium-scavenging abilities of this gelator. 
Here, a DBS-CONHNH2/agarose hybrid gel was immersed in a solution of PdCl2 over a period 
of 3 days. UV-vis spectroscopy measured an uptake of 8 𝜇mmol of palladium, indicative of a 
2:1 palladium:DBS ratio in the gel, suggesting that each acyl hydrazide may reduce a single 
palladium ion. Atomic absorption spectroscopy suggested a superb uptake of palladium, with 
over 99.97% of palladium from a palladium solution (0.83 mM, 3.6 mL) becoming embedded 
within the gel. In this process, DBS-CONHNH2 actively reduced palladium(II) to palladium(0) 
nanoparticles. This palladium-loaded hybrid hydrogel was then shown to be an effective 
catalyst for a series of Suzuki coupling reactions, reporting yields of up to 100% (see Figure 
11). Additionally, no loss of catalytic activity was observed until after the 11th use of the same 
palladium-loaded hybrid hydrogel. This was later built upon by the same group,116 with the 
palladium-loaded gels exhibiting catalysis of Sonogashira coupling with yields as high as 99% 
reported. The catalytic activity was retained for five consecutive runs. This method removes 
the requirement for a copper co-catalyst, allowing for less harsh reaction conditions, while 
also improving the environmental profile of the reaction by allowing it to be performed in 
more environmentally friendly solvents (EtOH/H2O). Heck coupling was also explored here, 
with efficient catalysis observed when using the electron-deficient 4-iodonitrobenzene. In 
this same study, gold was also explored as a possible catalyst, with the formation of gold 




Figure 11: (Left) TEM images of Pd nanoparticles formed in the hybrid hydrogel. Image adapted from Ref. 115.  
(Right) Sonogashira coupling of 4-iodonitrobenzene and phenylacetylene. 
Smith and co-workers117 have also explored the use of DBS-CONHNH2 as a cell growth 
medium. Here, DBS-CONHNH2 was combined with the polymer gel agarose, the biopolymer 
heparin, and heparin-binding C16-DAPMA micelles. Promising cell growth was observed at 
lower (25 𝜇g) concentrations of heparin, with an increase in metabolic activity of the cells 
over the course of 7 days. A cell migration assay confirmed that cells were adhering to the 
surface of DBS-CONHNH2. Additionally, cell growth was observed on pure DBS-CONHNH2 
whilst none was observed on agarose, indicating that the cell adhesion and growth is purely 
due to the presence of DBS-CONHNH2. Agarose, however, provides DBS-CONHNH2 with the 
required stiffness to act as a cell growth scaffold. 
 
The reactivity of the acyl hydrazide functional groups on the phenyl wings of DBS-CONHNH2 
has also been explored. Smith and co-workers118 further reacted these peripheral groups with 
the aldehydes vanillin, benzaldehyde, cinnamaldehyde, furfural, hexanal, and butanal, 
reporting that the gel structure was not disrupted and all hydrogels remained stable upon the 
formation of acylhydrazones. This work could provide the foundation for further 
functionalisation of DBS-CONHNH2 and exploration of more applications for this unique 
gelator. 
 
One further possible application of DBS-CONHNH2 is in the realm of drug delivery. The 
gelator’s previously explored tendency to interact and uptake dye molecules at a certain pH 
before releasing them at another may have the potential to be exploited with 
pharmaceuticals. To this end, Smith and co-workers119 explored the pH-mediated release of 
three anti-inflammatory drugs from DBS-CONHNH2: mesalazine (MSZ), naproxen (NPX), and 
ibuprofen (IBU). Initially, only MSZ could be loaded into the gel with the other two showing 
poor loading due to their hydrophobicity. This barrier was bypassed by mixing dry powder of 
the gelator and drug at a 1:1 molar ratio and then forming the gel. At 2:1 drug:gel molar ratio, 
excess drug precipitated out, indicating interaction between the two molecules interact 
similar to that observed with dyes. pH-mediated release was observed with NPX, with 33% of 
the loaded drug released over 24 hours at pH 7, compared to 100% released over the same 
time period at pH 8. This would make this formulation suitable for oral delivery, as the gel 
would pass through the stomach before reaching the intestine at pH 8 and releasing the drug. 













This work was then built upon by the same group.121 In this study, DBS-CONHNH2 was used in 
conjunction with PEG dimethacrylate (PEGDM) to form a hybrid gel. PEGDM was introduced 
to enhance the mechanical stiffness of the supramolecular DBS-CONHNH2. PEGDM is a photo-
activated hydrogel,122 enabling the photo-patterning of this hybrid hydrogel. The hybrid 
hydrogel was prepared by adding PEGDM and a photoinitiator (2-hydroxy-4ʹ-(2-
hydroxyethoxy)-2-methylpropiophenone) on top of a NPX-loaded DBS-CONHNH2 hydrogel 
prepared as in the previous report, followed by photopolymerisation. These gels were found 
to be free-standing and able to be handled, unlike pure DBS-CONHNH2. Drug release at pH 7 
and 8 was found to be 80-90% over a period of 24 hours. At pH 4, this was reduced to 25-30% 
over the same time period.  
 
Recently, the potential for multicomponent gel formulations for DBS-CONHNH2 and calcium 
alginate for drug delivery has been explored. Smith and co-workers123 have described the 
fabrication of self-assembled supramolecular hybrid gel beads with a core-shell structure (see 
Figure 12). Here, the LMWG phase is contained entirely within a polymer gel sphere, the first 
formulation of its kind. Here, a hot mixture of DBS-CONHNH2 and sodium alginate was added 
dropwise to a calcium chloride solution, and beads as small as 750 𝜇m were formed with over 
90% incorporation of DBS-CONHNH2 into the core of the bead. The core-shell structure was 
confirmed through optical microscopy. These gels were then loaded with palladium in a 
similar fashion to the DBS-CONHNH2/agarose hybrid gels. The loading was significantly poorer 
in the case of the core-shell beads, with only 33% of palladium uptake observed compared to 
the DBS-CONHNH2/agarose hybrid gel. This indicates interaction between the LMWG and 
alginate which may limit interactions with added molecules of interest and may have 
implications for drug loading in a pharmaceutical application. The palladium-loaded core-shell 
hybrid gel beads were then used for the catalysis of Suzuki coupling reactions, exhibiting 
similar catalytic performance as the palladium-loaded DBS-CONHNH2/agarose hybrid gel, 
with full conversion observed in the first two reactions. However, this catalytic activity drops 
much faster than observed in the previous gel formulation, with only consecutive reactions 
being possible compared to eleven. Regardless, this was a promising initial study into the 
formulation and application of DBS-CONHNH2/alginate core-shell beads. 
 
 
Figure 12: Formation of palladium-nanoparticle-loaded LMWG/alginate core-shell beads. 
DBS-CONHNH2/alginate beads may also be formulated for use in biomedical applications. 
Smith and co-workers124 recently reported the use of these beads to reduce silver in situ to 
form silver nanoparticles with antimicrobial properties. Here, gel beads (c. 3 mm diameter) 
were immersed in silver nitrate and allowed to interact for 3 days. A colour change indicated 
the formation of silver nanoparticles within the gel. The silver-loaded hybrid gel exhibited 





faecium and the Gram-negative Pseudomonas aeruginosa, while gels without silver 
nanoparticles did not exhibit any bacterial inhibition. This antimicrobial property, coupled 
with the ease of handling and mechanical stiffness, makes these beads excellent candidates 
for wound-healing applications. 
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2. Aims and Objectives 
In the present body of work, it was planned to combine the aforementioned concepts in order 
to formulate multicomponent gel beads on the nanometre scale. Ideally, these beads will be 
below 200 nm in diameter, so as to benefit from the EPR effect where it is present and 
improve the targeted delivery of an anti-tumour payload. The knowledge of hybrid gel 
nanoparticles formed through the reverse emulsion method will be built upon, working with 
the LMWG DBS-CONHNH2 to help limit the size of the alginate beads instead of using two 
different polymer gels to do so. The previous work of the Smith group will be built upon, 
specifically the fabrication of core-shell hybrid gel beads. It is hoped that, by altering the 
experimental parameters for this formulation, a reduction in bead diameter will be achieved. 
The parameters which will be altered are oil phase volume, temperature, stirring time, 
sonication, and the oil phase itself.  
 
 
Figure 13: Schematic illustrating the main aims of the study. Briefly, a method to form microbeads of roughly 1000 nm in 
diameter will be built upon in order to fabricate beads of <200 nm diameter. These beads will then be functionalised with 
magnetic nanoparticles (black dots) with the aim of adding magnetic properties to the beads. 
The incorporation of superparamagnetic iron oxide nanoparticles into the bead will also be 
explored. These nanoparticles will be synthesised using the co-precipitation method and will 
be added to the gelator mixture with the goal of forming beads with magnetic properties. It 
is hoped that these beads will exhibit attraction to an applied magnetic field, with the ultimate 
goal of use in targeted drug delivery. The possibility of in situ magnetic nanoparticle formation 
will also be explored by doping the LMWG and alginate with ferric chloride. The proposed in 
situ nanoparticle formation aims to bypass the requirement of synthesising iron oxide 
nanoparticles separately, simplifying the formulation of magnetic nanogels. 
 
It is then hoped that the drug uptake and release properties of the nanogels will be explored. 
DBS-CONHNH2 has already been shown to be effective for pH-mediated uptake and release 
of anti-inflammatory drugs and it is theorised that this property may be exploited for pH-
mediated release of anti-cancer drugs. This hypothesis combines the possibility of exploiting 
the EPR effect where present and the knowledge of the slightly acidic tumour 
microenvironment in the hope of improving the dose of a drug which reaches a solid tumour. 
By adding superparamagnetic functionality to the beads, the potential for active drug 
targeting may be realised, further improving the efficacy of the formulation. 
 
The ability of the LMWG to form nanoparticles through the in situ reduction of metal salts will 
be further explored through the introduction of copper chloride. It is proposed that DBS-
CONHNH2 will form copper-containing nanoparticles. An application of the copper 
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nanoparticles will then be chosen, utilising either their catalytic or antimicrobial properties. 
As silver has already been investigated by the group for its antimicrobial properties, it is likely 
that catalysis will be the chosen application of the copper nanoparticles. In this case, a copper-
catalysed azide-alkyne cycloaddition (CuAAC) reaction will be chosen. 
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3. Results and Discussion 
3.1 Synthesis of 1,3:2,4-dibenzylidene-D-sorbitol (DBS) CONHNH2 
DBS CONHNH2 and its precursor DBS CO2Me were successfully synthesised via previously 
reported literature methods (see Schemes 1 and 2).112, 113 Briefly, D-sorbitol and 4-
methylcarboxybenzaldehyde were mixed in a 1:2 ratio in acidic conditions at 70 ℃ using 
Dean-Stark apparatus to synthesise DBS-CO2Me. Hydrazine was then added to a suspension 
of DBS-CO2Me, and this mixture was left under reflux conditions overnight for the conversion 
to DBS-CONHNH2. The products were characterised by 1H NMR, ESI MS, and IR spectroscopy. 
 
 
Scheme 1: Synthetic scheme for DBS-CO2Me 
 
 
Scheme 2: Conversion of DBS-CO2Me to DBS-CONHNH2 using hydrazine monohydrate 
The 1H NMR spectra of both DBS-CO2Me and DBS-CONHNH2 (see Appendices 1 & 2) were in 
accordance with previous literature findings.112, 113 
 
The 1H NMR spectrum of DBS-CO2Me depicts both aromatic resonances attributed to protons 
and a complex set of resonances arising from the sugar backbone of the molecule. The 
complexity of the sugar backbone region may be due to the presence of several 
diastereotopic protons. Upon conversion to the hydrazide, a resonance corresponding to the 
NH protons was observed at 𝛿 = 9.76 while the methyl peak corresponding to the -CO2Me 
group, previously observed at 𝛿 = 3.82, was no longer evident. This indicates successful 
conversion from DBS-CO2Me to DBS-CONHNH2. Mass spectrometry of the products showed 
mass ions corresponding to the mass of DBS-CO2Me and DBS-CONHNH2, both at m/z 475.2. 
 
In summary, the principal synthetic procedure was performed successfully and a uniform 
















































thermally triggered hydrogelation. The characterisation data obtained was in accordance 
with previous literature data.113 
 
3.2 Synthesis of Iron Oxide Nanoparticles 
Magnetite nanoparticles were synthesised following an adapted literature method.125 In 
brief, ferric and ferrous chloride were mixed in a 2:1 ratio in aqueous conditions under an 
inert atmosphere. A capping agent, 0.226 g of sodium n-dodecyl sulfate, was added 
concurrently with ammonium hydroxide to trigger the precipitation of the iron oxide 
nanoparticles. The reaction proceeds as: 
 
2𝐹𝑒+, + 𝐹𝑒-, + 8𝑂𝐻. → 𝐹𝑒+𝑂/ + 4𝐻-𝑂 
 
A dry, black powder was obtained in this experiment (Figure 14). This powder exhibited 
attraction to an applied magnetic field from a neodymium magnet, indicating the successful 
formation of a superparamagnetic iron oxide species. The strong IR absorbance bands 
observed at 554 cm-1 in the infrared spectrum is characteristic of Fe-O bond vibrations.126 The 
series of small, almost unnoticeable IR absorbance bands in the fingerprint region are likely a 




Figure 14: IR Spectrum of the obtained product (left). Black powder indicating the formation of magnetite (right). Product 
exhibiting attraction to applied magnetic field shown through the use of two neodymium magnets (right). 
 
Initially, poly(ethylene glycol) was used as a capping agent, but this was found to be a poor 
capping agent and considerable aggregation of the nanoparticles was indicated by 
sedimentation and the cessation of Brownian motion. This was unexpected due to the success 
with this capping agent shown by Ajitha et al.127 Subsequently, sodium n-dodecyl sulfate was 
used as the capping agent, as was reported to be possible by Karunakaran et al.,128 resulting 
in more satisfactory nanoparticle formation and stability. In a preliminary experiment, sodium 
n-dodecyl sulfate was shown to not interfere with the gelation of DBS-CONHNH2 at or below 
a 1:1 molar ratio, so it was deemed suitable for future experiments involving the combination 
of the nanoparticles and the multicomponent gel beads. 
 
Evidence of magnetite formation is shown through the IR spectrum (Figure 14) of the sample, 
with the resonance observed at 538 cm-1 being indicative of iron-oxygen bond formation. 
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observed over time. Oxidation of magnetite nanoparticles in water between 24 and 80 ℃ has 
been shown by Tang et al.129 This indicates oxidation from magnetite to maghemite and, 
although not entirely ideal, is fine as maghemite retains the superparamagnetic properties 
observed in magnetite and exhibits bulk ferromagnetic behaviour. When imaged using TEM, 
a spherical morphology was observed, and the nanoparticles were seen to be around 10 nm 
in diameter (see Figure 15). At this size, they are small enough to yield single-domain magnets 
and exhibit superparamagnetic properties. The aggregation observed in the TEM images is 
most likely a result of the sample preparation process for TEM analysis and not a result of 
poor synthetic technique. This is evident through the dispersion of nanoparticles in the 
solvent, indicating an absence of excessive aggregation. There is the possibility that partial 
aggregation occurred in the sample, though not to the extent to which excessive 
sedimentation would occur. 
 
 
Figure 15: TEM images of iron oxide nanoparticles at 49,000 x (left) and 150,000 x (right) magnification. 
Overall, magnetite nanoparticles were synthesised successfully for the purpose of integration 
into the multicomponent gel beads. These nanoparticles were characterised by IR 
spectroscopic analysis and simple magnetic attraction. When imaged with TEM, the size of 
the iron oxide nanoparticle was confirmed to be suitable for use in the multicomponent gel 
beads. 
 
3.3 Fabrication of Multicomponent Gel Beads 
3.3.1 Fabrication of Multicomponent Gel Beads 
The main body of work in this project revolved around the fabrication of multicomponent gel 
beads, consisting of the polymer gel calcium alginate and the supramolecular gel DBS-
CONHNH2. The beads had previously been developed at the micrometre scale.123 The main 
aim here was to investigate a manner in which the beads could be fabricated at smaller 
diameters. In particular, it was hoped that beads could be fabricated below the injection 
threshold, which is usually considered to be around 200 nm for optimal exploitation of the 
EPR effect.130 The rationale behind this is that the beads would ideally act as a biocompatible 
drug delivery vehicle and, when combined with magnetic nanoparticles, could potentially 
exhibit directed, dual-action anti-tumour activity.  
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Gel beads were fabricated using adaptations of a previously reported method.123 Briefly, a 
non-polar organic solvent (either paraffin oil, ethyl acetate, amyl acetate, n-butyl acetate, 
heptane, or hexane) was used as an oil phase into which a non-ionic surfactant (Span80) was 
dispersed. The aqueous phase, containing the both the polymer gelator (sodium alginate) and 
the supramolecular gelator (DBS-CONHNH2), was then heated and dropped (20 𝜇L/drop) over 
a 2-minute period into the oil phase under vigorous stirring. Calcium chloride then added to 
initiate the gelation of alginate. The product was then separated from the oil phase through 
centrifugation and washed in this manner multiple times. Finally, the product was stored in 
distilled water. Here, the DBS-CONHNH2 is forming a gel as it cools while alginate gelation is 
initiated through the introduction of Ca2+ ions. 
 
Between 6 and 10 centrifugation steps were performed in this procedure (10 when using 
paraffin oil, 6 when using any of the other oil phases) in order to achieve sufficient washing. 
In the case of paraffin, the paraffin itself was centrifuged before the supernatant was 
discarded. The obtained pellet was then dispersed in ethyl acetate and centrifuged again. The 
supernatant was then discarded, and this process was repeated twice more with ethyl 
acetate, three times with ethanol, and three times with water.  This was always performed at 
4990 rpm, as this was the maximum setting which could be achieved with the available 
equipment. This number of centrifugation steps may affect the yield of the beads, as not all 
beads will be collected through centrifugation and will remain suspended in the supernatant 
when it is discarded. According to the Stokes-Einstein equation, there is likely to be a greater 
distribution of smaller beads left in the supernatant and subsequently lost. 
 
Using Stokes’ Law of Centrifugation, it can be predicted that it would take around 5 days of 
constant centrifugation at 4,990 rpm to achieve 100% yield in paraffin wax. Larger particles 
are sedimented faster as they are more affected by the gravitational force exerted by the 
centrifuge. It could therefore be said that the results seen in the DLS are not an accurate 








Equation 1: Stokes' Law of centrifugation. The equation on the left states how the velocity of the sphere is calculated, whilst 
the equation on the right states how the time to settle is calculated. 
𝜈 = velocity of sphere. 𝑟 = radius of sphere. 𝑝= density of sphere. 𝐿 = density of medium. 𝑔 = gravitational force. 𝜂 = viscosity 
of medium. 𝑡 = time to settle. ℎ = height. 
Stokes’ Law states that the velocity of the sphere is largely dependent on the gravitational 
force enacted upon it. Therefore, the yield here could most simply be improved by increasing 
the rpm on the centrifuge. Unfortunately, the centrifuge available experienced rotor errors 
whenever an attempt was made to exceed 5,000 rpm. In future, other isolation methods 
could be attempted, such as dialysis. 
 
Due to the low mass of materials being handled in this process, the yield was calculated using 
quantitative NMR spectroscopy. Briefly, the product was dissolved in deuterated DMSO. This 
destroys the gel structure and thus the gel beads themselves, nullifying the problems 
encountered with attempting to perform an NMR spectroscopic measurement on a gel. To 
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this solution, a known amount of dry acetonitrile (2 𝜇L, 0.0383 mmol) was injected 
immediately before transferral to a capped tube to prevent evaporation, and used as a 
standard against which the integrals of the DBS-CONHNH2 peaks would be compared in order 
to ascertain the yield.  
 
Species Integral Relative Quantity Concentration (mM) 
CH3CN 30.00 1 28.6 
DBS-CONHNH2 
Unfiltered 
0.98 0.024 0.69 
DBS-CONHNH2 
Filtered 
0.23 0.0058 0.16 
Table 1: Quantitative NMR yields for DBS-CONHNH2 beads in paraffin oil. 
0.23
4 = 0.0575	𝑀 
0.0575
10 	× 0.0286 = 1.64 × 10
./	𝑚𝑀 = 0.075	𝑚𝑔/𝑚𝐿	 
Equation 2: Calculation of mass of sub-400 nm DBS-CONHNH2 beads 
0.98
4 = 0.245	𝑀 
0.245
10 	× 0.0286 = 7 × 10
./	𝑚𝑀 = 0.33	𝑚𝑔	400	𝜇𝐿.0 = 0.83	𝑚𝑔	𝑚𝐿.0	 
Equation 3: Calculation of total yield of DBS-CONHNH2 beads 
Firstly, the integral for acetonitrile is normalised to 30.00, meaning the per-proton integral is 
10. The per-proton integral for the amine group of DBS-CONHNH2 in each sample is then 
calculated. DBS-CONHNH2 contains 4 -NH2 protons, so the per-proton integral is calculated as 
integral
/
. The relative quantity of DBS-CONHNH2 is then calculated by dividing the per-proton 
integral of DBS-CONHNH2 by the per-proton integral of acetonitrile. The relative quantity of 
DBS is then multiplied by the concentration of acetonitrile (0.0286 M) to give the 
concentration of DBS-CONHNH2 in the final product and thus the yield. 
 
When using paraffin oil, the yield was 28%, with 9% of these beads being present after the 
product was passed through a 400 nm filter. While this yield is not terrible, it is not ideal. The 
yield is likely due to both the number of centrifugation steps – increasing the likelihood of 
product loss during transfer – and the centrifugation itself.  
 
Dynamic light scattering (DLS) was used to assess the size of each set of samples. DLS is an 
important technique in this process as it is useful in determining the distribution of sizes of 
particles in suspension, allowing for the assessment of the success in reducing the size of the 
beads. DLS works by directing a monochromatic beam of light into a suspension of particles. 
These particles, in Brownian motion, scatter the light when it hits. The pattern of scattered 
light detected by the equipment is related to the speed of diffusion in suspension, which is in 
turn related to the hydrodynamic radius of the particle, assuming the particles are spherical, 








Equation 4: Stokes-Einstein equation relating hydrodynamic radius to diffusion speed. D = diffusion speed, k = Boltzmann 
constant, T = temperature, 𝜂 = viscosity, DH = hydrodynamic radius. 
The particle size can be reported in terms of an intensity distribution or a volume distribution. 
In this case, results are reported in terms of volume of particles, rather than the intensity of 
scattering, at each size. This is because a small number of larger particles may scatter light 
much more than a large number of smaller particles. This would result in a distribution 
suggesting the average particle diameter is much larger than it is in reality. Therefore, the 
volume of particles at each size is used, as the area of the peak will correspond to the number 
of particles, allowing for the determination of the bulk size. Additionally, Z-average is not used 
in this investigation when analysing samples that have not been filtered. This is because, when 
not filtered, there may be artifacts in suspension larger than the scope of DLS, but which still 
scatter light and subsequently skew the results to a larger Z-average. The reason filters are 
not used initially is because the size of the beads in each case will not be known unless the 
entire sample is analysed. Should a sample show promise, then it will be filtered using a 450 
nm filter and subsequently analysed. In this case, Z-average will be used as the measure for 
particle size. 
 
One of the limitations of DLS analysis is that it becomes less accurate with increasing particle 
size. With particles greater than 1000 nm in diameter, the results cannot be considered 
accurate. Fortunately, for the purposes of this experiment, simply knowing that the particles 
are greater than 1000 nm in diameter is enough, as the ultimate aim is to achieve particles 
far smaller than this. A further limitation of DLS analysis may be that the sample may sediment 
during analysis, resulting in inaccurate results. This may be mitigated by decreasing the 
density of the sample, which is performed in this case by diluting the sample in 1 mL of water 
before analysis. 
 
3.3.2 Effects of Changing Experimental Parameters on Bead Size 
In order to ascertain which experimental parameter affected the ultimate diameter of the gel 
beads, individual parameters were changed until a change in diameter was noticed. Initially, 
the volume of the oil phase was altered from 40 mL to 200 mL. It was hypothesised that, by 
increasing the area into which droplets of the surfactant can disperse, these droplets would 
break up into smaller, more numerous micelles. This would subsequently result in a smaller 
bead size. Unfortunately, this was not the case and the bead diameter appeared to be 




Figure 16: DLS results exhibiting the effect of increased volume on gel bead size. 
At both 40 mL and 200 mL of paraffin oil, the beads were observed to be around 1500 nm in 
diameter, indicating there is no correlation between bead diameter and the volume of the oil 
phase (see Figure 16). Of course, while one of the limitations of DLS analysis is that it is not 
accurate above 1000 nm, these results may still be accepted as beads were not observed 
below 1000 nm, indicating no reduction in bead size regardless of the accuracy of DLS analysis 
in this case.  
 
Interestingly, a more uniform size distribution is observed at a higher volume of oil, with the 
peak at 5560 nm observed at 40 mL not being observed in the analysis of the sample prepared 
in 200 mL paraffin oil. This may suggest that the idea of surfactant-stabilised microdroplets 
being able to disperse more uniformly at higher volumes may hold some merit. However, in 
terms of industrial application, increasing the volume of the oil phase five-fold simply to 
double the volume of beads at the desired size may not be economically or environmentally 
viable. On a more positive note, however, the fact that bead size is unaffected by oil phase 
volume is promising for any industrial scaling-up of the procedure, perhaps allowing for large-
scale fabrication of beads in large quantities of oil-phase. 
 
The next parameter to be investigated was the temperature at which the procedure was 
carried out. Here, it was believed that increasing the temperature and thus decreasing the 
viscosity of the oil phase may aid in the dispersion of the non-ionic surfactant, and also allow 
for the DBS-CONHNH2 to disperse into smaller droplets before it gelates. As DBS-CONHNH2 is 
a thermally triggered gelator, dropping it into a hot oil phase would delay gelation until the 
mixture is cooled. Therefore, the initially-formed water droplets may be able to break up into 
smaller droplets before gelation is initiated than when a room temperature mixture is used. 
However, it was observed that the increase in temperature did not affect the bead size, with 
















Comparison of the Effect of Volume of Oil Phase on the Size 
of Multicomponent Gel Beads
40 mL Paraffin Oil 200 mL Paraffin Oil
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Figure 17: DLS results comparing the effect of temperature on gel bead size 
The bead size observed in both conditions was around 1500 nm (see Figure 17). It may be the 
case that the dispersion of the non-ionic surfactant is unaffected by the temperature of the 
reaction mixture, and the subsequent size of the surfactant-stabilised water droplet, is the 
determining factor in the bead size. Furthermore, the viscosity of paraffin oil is orders of 
magnitude greater than the viscosity of other oil phases available, and therefore the 
difference in viscosity between 25 ℃ and 95 ℃ may not be significant enough to induce 
noticeable change in the size of the beads. 
 
Interestingly, increasing the temperature should reverse the order of gelation in this 
procedure. DBS-CONHNH2 is a thermally triggered gelator. Once heated above its gelation 
temperature, it will form a gel upon cooling. At 25 ℃, DBS-CONHNH2 will gelate rapidly upon 
addition to the oil phase, followed by the gelation of alginate on addition of calcium chloride. 
At 95 ℃, however, the DBS-CONHNH2 will not form a gel until the mixture is cooled after the 
addition of calcium chloride. This may have the effect of altering the physical makeup of the 
beads. It is likely that, at 95 ℃, the gelation of alginate will occur at the outermost zone of 
the droplet, forming a solid-like shell inside which the DBS-CONHNH2 will subsequently gelate, 
resulting in an ideal core-shell bead. At a lower temperature, however, it is more likely that a 
bead with no distinct core-shell structure is formed.  
 
Another parameter which was adjusted was the stirring time. The 20-minute stirring step 
after the addition of calcium chloride was changed to 10 minutes and 1 hour. It was predicted 
that, by increasing the stirring time, the droplets may be dispersed to a greater degree and 
divided into smaller beads, resulting in smaller bead size. To a certain degree, this is what was 
















DLS results comparing the effect of temperature on the size 
of multicomponent gel beads
95 ℃ 25 ℃
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Figure 18: DLS results showing a comparison of the effect of stirring time on bead size. 
There does seem to be a correlation between stirring time and average bead size. Whilst the 
main peak for both is observed at ca. 1500 nm, a larger volume of beads was observed at this 
size after 1 hour of stirring compared to just 10 minutes of stirring. With shorter stirring times, 
there was a greater contribution from large size particles. However, the bead size appeared 
to be limited to ca. 1500 nm by a different parameter. Regardless, it is important to know that 
an increased stirring time does aid in increasing the volume of the smallest possible beads, in 
line with what was hypothesized. This also helps to overcome the problem observed with 
large beads being present when 40 mL of the oil phase was used. By increasing the stirring 
time, the need to increase the volume is eliminated. However, industrially, this would 
introduce additional time into the procedure, reducing efficiency. Nonetheless, the 
importance of stirring time is highlighted here, and the correlation between stirring time and 
the polydispersity of the final product. The use of an industrial-grade overhead stirrer may 
yield greater control over the final product size, with greater control over the rate of stirring. 
However, the overhead stirrer which was available for this experiment was not able to reach 
the stirring rates achieved by a magnetic stirrer. The overhead stirrer was therefore not used 
for the fabrication of beads in this case. 
 
The method of dispersing the reagents was also altered from magnetic stirring to sonication. 
Here, it was hoped that the ultrasonic vibrations may fragment the droplets in the oil phase 
to a greater degree than stirring can achieve. Briefly, the reaction vessel was suspended in an 
ultrasound bath and the procedure was carried out in its entirety while being sonicated. The 
resulting product was significantly poorer in quality than when stirring is used as the 
dispersion method. Such was the poor quality of the product, that DLS analysis was not 
required to measure the diameter, as it was in the millimetre size range. Clearly, significant 















Comparison of the effect of stirring time on Bead size
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Figure 19: Gel clump obtained from conducting the procedure under sonication. Note that the brown colouration is due to 
the presence of iron oxide nanoparticles. 
After exhausting our exploration of physical parameters, the oil phase itself was changed. 
When selecting an oil phase, several factors were considered. The oil phase would, of course, 
need to be non-polar and immiscible with water to allow for the formation of a surfactant-
stabilised water-in-oil emulsion. Secondly, the viscosity would ideally be far lower than the 
viscosity of paraffin oil. A lower viscosity should, ideally, allow for faster dispersion of the 
reagents and faster breakup into smaller droplets, resulting in smaller bead size. Thirdly, the 
oil phase would ideally be non-toxic, or of low toxicity. As the beads are being fabricated with 
biomedical applications in mind, any toxic compounds which may be present in the final 
product are unacceptable. This issue may, however, be mitigated with thorough washing of 
the product to remove unwanted oil phase. With these considerations in mind, the oil phases 
chosen for screening were ethyl acetate, n-butyl acetate, amyl acetate, heptane, and hexane. 
 
Ethyl acetate was chosen as it had previously been shown to be an effective organic phase 
for the preparation of alginate nanocapsules.131 Heptane was chosen because of its low 
polarity, low viscosity, high boiling point for potential hot synthesis, and relatively low toxicity. 
Furthermore, unlike ethyl acetate, it will not have issues arising from possible hydrolysis in 
contact with water. Hexane was used because it has lower polarity and lower viscosity than 
heptane and should therefore yield better results. Toxicity concerns were taken into account 
with hexane, and the washing stages were increased to maximise removal of the oil phase. 
 
Initially, the procedure was conducted in the same manner as with paraffin oil. The 
experimental parameters were not changed except the nature of the oil phase. It was 
observed that beads were not formed under these conditions, and instead a clump of gel was 
forming as with sonication (see Figure 20). It was decided that a stabiliser should be added to 




Figure 20: Clumps of gel observed when a less viscous oil phase (heptane) was used. 
Glycerol was chosen to act as a stabiliser in this procedure – its non-toxicity and high viscosity 
made it an ideal candidate for this role. Glycerol is a humectant, and its hygroscopic 
properties should help to facilitate the water-in-oil emulsion. After adding 1 mL of glycerol, 
clumps were not observed, and beads were formed successfully. These beads were 
significantly smaller than those observed when using paraffin oil, reaching the nanometre 
scale and, when using hexane or heptane, dropping below the 200 nm target. Furthermore, 
the introduction of glycerol resulted in the formation of two layers in the mixture due to its 
immiscibility with these new oil phases. This glycerol layer was believed to contain the 
majority of the product, as any product not in the glycerol layer would theoretically have 
precipitated in the same manner as in the absence of glycerol. The glycerol was removed from 
the product using ethanol and water washing steps. The oil phase, therefore, was not present 
in the washing steps in this case. 
 
 
Figure 21: Comparison of the DLS results showing bead size when changing the oil phase. 
Altering the oil phase was seen to have the most profound effect on the size of the beads (see 
Figure 21). Paraffin oil produced beads with a diameter mainly around 1500 nm, while this 
was reduced to 615 nm with n-butyl acetate and then to 190 nm with heptane. When passed 



















Comparison of the size of multicomponent gel beads by DLS 
distribution by volume 
Paraffin Oil Ethyl Acetate Heptane n-Butyl Acetate Amyl Acetate Hexane
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bead sizes is probably a result of the lowered viscosity of these oil phases. This allows droplets 
of gel to be broken up faster upon addition to the stirring oil phase, resulting in smaller 
nanobeads before gelation occurs. Heptane, for example, has a viscosity of 0.389 cP while 
ethyl acetate has a viscosity of 0.426 cP. The lower viscosity of heptane here appears to have 
resulted in smaller bead size. It is also possible that the far lower dipole moment of heptane 
compared to ethyl acetate has an effect on the bead size, perhaps effecting more greater 
hydrophobicity and thus smaller beads. To determine which factor was more important, 
multiple solvents were tested. Comparison between the oil-phases (Figure 22) suggests there 
is a clear correlation between viscosity and particle size. This correlation is near-linear in 
nature, though more data points are perhaps needed at intermediate viscosities. 
 
 
Figure 22: Graph showing the correlation between oil phase viscosity and bead size. 
The ability to fabricate beads below 200 nm is an exciting revelation, allowing for the 
development of these beads with a biomedical goal in mind. Below this diameter, gel beads 
are an acceptable size for intravenous injection and can be considered for drug loading. 
Additionally, the correlation between oil phase viscosity and bead size may allow for the 
preparation of tailor-made beads of specific sizes for applications outside of intravenous drug 
delivery. Between 200 – 1000 nm, for example, the beads could be used for oral drug delivery. 
Prior to this, of course, the efficacy of the method in terms of purity of product and yield must 
be evaluated. Initially, IR spectroscopic analysis revealed that none of the non-ionic surfactant 
(Span80) is present in the product (Figure 23), which is promising as it indicates thorough 





































IR Spectra of DBS-CONHNH2 Beads
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Unfortunately, the yield when using either hexane or heptane as the oil phase was too low to 
be detected by NMR spectroscopic analysis under standard parameters. Again, this could be 
explained by Stokes’ Law: DLS analysis shows that the beads are mostly around 200 nm in 
diameter, therefore they will take even longer to settle than the beads formed in paraffin oil. 
The substantial decrease in size is enough to offset the increase in velocity which would be 
observed through the absence of the oil phase in washing. Again, in order to increase the 
yield here, greater gravitational force will need to be exerted on the beads in order for them 
to settle and collect as a pellet at the base of the centrifuge tube. A smaller volume of oil 
phase could also be used to reduce the distance the bead needs to travel, h, to settle. 
Summarily, it appears that the centrifugation step is the main barrier to achieving greater 
yield, and that increasing the gravitational force is the simplest way to improve. 
 
Another effect of using either heptane or hexane which was taken into consideration was the 
potential environmental impact of these compounds. Both are serious environmental hazards 
and, while 40 mL at a time is a relatively small quantity, the amount used adds up over time, 
especially if the process were to be used on an industrial scale. Increasing concerns around 
environmental pollution and climate change mean that new processes should, ideally, be 
developed with environmentalism in mind. To this end, it was proposed that no beads would 
remain in the oil phase in the process involving glycerol – all beads would be in the glycerol 
layer. This would result in the oil phase retaining its purity throughout the procedure, allowing 
it to be reused and eliminating environmentally hazardous waste. To investigate this, the oil 
phase was separated from the glycerol layer and analysed using NMR spectroscopy. The 
spectrum obtained for heptane was relatively pure, indicating the potential for reusing this 
oil phase and reducing environmental waste. However, the spectrum obtained for hexane 
contained some impurities and shows that this procedure would not have as much green 
potential as when using heptane (see Figure 24).  
 
 
Figure 24: NMR spectra for used heptane (left) and hexane (right) 
While this is not ideal as hexane yielded the smallest beads, it may be preferable to turn to 
heptane as an alternative. It is not as toxic as hexane and so its use in the fabrication of 
biomedical materials is not as concerning. It yields similar bead sizes to hexane, and these 
may be further improved upon by altering physical parameters such as increased stirring 
speed. Furthermore, heptane has a far higher boiling point than hexane, allowing for the 
fabrication of multicomponent gel beads at a higher temperature which, as previously 
mentioned, would be more likely to result in a core-shell structure. This would simply not be 
possible using hexane with its boiling point of 69 ℃ when compared to that of heptane (98 
℃). From this conclusion, hot fabrication was attempted in heptane. It was hoped that, in 
accordance with the temperature-independent size observed in paraffin oil, the beads 
formed would remain at the 190 nm diameter observed at room temperature. 
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Unfortunately, the beads formed were ca. 1300 nm in diameter, more than five times larger 
than the diameter observed in room temperature (see Figure 25). This is not ideal, as a 
successful fabrication of sub-200 nm beads at this temperature would have been an 
important step forward. However, this can likely be explained through the differences in 
physical setup, rather than an odd temperature-dependence occurring when using heptane. 
At room temperature, a cross-bar stirrer was used in a 100 mL beaker, whereas when 
performing the procedure in an oil bath a rounded stirrer was used in a 100 mL round-bottom 
flask. The cross-bar stirrer has the effect of inducing a greater and more vigorous vortex in 
this procedure, inducing greater fragmentation of droplets and therefore smaller bead size. 
Should the procedure be replicated exactly, with a beaker suspended in an oil bath using this 
stirrer, smaller beads should be observed. The procedure would have been repeated using a 
cross-bar stirrer had there been more time remaining for the project. 
 
 
Figure 25: DLS graph for beads formed in hot heptane. 
 
3.3.3 Addition of Magnetic Nanoparticles to Gel Beads 
The possibility of adding magnetic nanoparticles to the beads was then explored. This was 
done with the intention of adding ferromagnetic properties to the beads so that they could 
be directed in solution using an applied magnetic field. This would be a key step towards 
realising a dual-action drug delivery vehicle which can be directed towards a target site using 
an applied magnetic field. These nanoparticles, previously synthesised and presented as a 1 
mg/mL suspension, were added to the gel mixture at the beginning of the procedure in the 
hope that the gel would form with the nanoparticles present within the gel. As a proof-of-
concept experiment, this was first performed with millimetre-sized multicomponent beads, 
and it was observed that gelation was not impeded by the presence of iron oxide 
nanoparticles. Furthermore, these beads exhibited attraction to an applied magnetic field. 
 
Following this, the effect of iron oxide nanoparticles on the size of the beads was investigated. 
It was hoped that these nanoparticles would not affect the bead size, and beads in the 
nanometre size range would still be formed. This was investigated using amyl acetate as an 
oil phase, and the results were in line with the hypothesised scenario. The beads formed were 














DLS Graph for Beads Formed in Hot Heptane
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of iron oxide nanoparticles. This is an ideal result, as it shows that the incorporation of iron 
oxide nanoparticles is not a barrier to achieving injectable multicomponent gel beads.  
 
 
Figure 26: DLS Graph showing the size of gel beads formed in the presence of iron oxide nanoparticles. 
While the product displayed a light brown colouration, indicating the presence of iron oxide 
nanoparticles, this is not sufficient evidence to show the nanoparticles are in the beads. These 
iron oxide nanoparticles could be suspended freely in the final product, completely separate 
to the beads. In order to determine incorporation into the beads, TEM microscopy was used 
to image the gels (see Figure 27). While the sample preparation procedure results in the 
aggregation and destruction of the beads, the iron oxide nanoparticles should still be 
observed in the gel structure rather than external to it. 
 
 
Figure 27: TEM image of iron oxide nanoparticles within the gel structure. Imaged at 49,000x. The gel (G) and outer region 
(O) are separated by the highlighted membrane. 
While difficult to see due to the poor contrast obtained with a gel in TEM, it can be seen that 
the iron oxide nanoparticles are contained within the gel, rather than external to it. This is an 
important observation, as it indicates the success of this procedure in fabricating 
multicomponent gel beads with ferromagnetic properties. These beads should exhibit 
attraction to an applied magnetic field and, depending on the strength of this field, should be 




















Overall, this section of research can be considered a success. According to DLS results, beads 
are being fabricated below the injectable limit of 200 nm and, moreover, there is scope to 
develop custom-made beads of predetermined sizes by selecting different oil phases. The 
final product is clean, as shown by IR spectroscopy, and does not contain traces of the oil 
phase or the non-ionic surfactant. This means that the beads should retain the 
biocompatibility and non-toxicity which is characteristic of calcium alginate and DBS-
CONHNH2, allowing them to be used for possible biomedical purposes. Furthermore, the new 
process has green potential when using heptane, as the oil phase is left clean after separating 
it from the glycerol layer, allowing it to be reused and preventing environmentally hazardous 
waste from being discarded. Industrially, this would also improve the economic viability of 
the process, reducing the volume of oil phase required to repeat the process. Additionally, 
iron oxide nanoparticles have been added successfully to the beads, imparting ferromagnetic 
properties unto them without affecting their size. The main failure of the novel method is the 
poor yield, but this can be explained by way of insufficient centrifugation and can be rectified 
through an increase in gravitational force in order to achieve a greater yield. 
 
3.4 Doping gels with metal salts 
Following this, it was proposed that there may be a way to form iron oxide nanoparticles in 
situ – that is, formed within the gel beads rather than being synthesised separately and added 
during the fabrication process. Typically, to form iron oxide nanoparticles, a base is added to 
a mixture of ferrous and ferric ions. DBS-CONHNH2 is both basic and has been shown to act 
as a reducing agent to reduce palladium for catalysis. While iron has a lower reduction 
potential than palladium, there remained the possibility that DBS-CONHNH2 would be able to 
form iron oxide nanoparticles in situ. Furthermore, it has previously been shown to be 
possible to form iron oxide nanoparticles starting from only ferric ions, as opposed to a 
mixture of ferric and ferrous ions. It was also speculated that this approach could be 
multifaceted, and the DBS-CONHNH2 could be used to adsorb ferric ions from water, perhaps 
as an environmental application. This was explored first, and the uptake of ferric ions by the 
gel was investigated prior to determining the fate of the ions within the gel. 
 
3.4.1 Iron Chloride and DBS-CONHNH2 
This was initially tested using a bulk sample of the gel, rather than the gel nanobeads, in order 
to facilitate the analysis. Briefly, a method was devised wherein 1 mL of a 0.1 M metal salt 
solution was layered on top of a 1 mL 0.4% wt/vol DBS-CONHNH2 gel in a vial and the uptake 
of metal ions was measured via UV-vis spectroscopy over a period of three days. The solution 
in which the gel was stored was measured, rather than destroying the gel itself, and so a 
reduction in the intensity of the absorbance max was expected. Ferric ions possess no useful 
UV-vis properties, and so this method would be unsuccessful without treatment of the 
solution once it had been removed from the gel. In this case, the solution was treated with 
potassium thiocyanate, which forms a blood-red, UV-active solution when introduced to 
ferric ions (Equation 5). The complex strongly absorbs at 450 nm and can therefore be 
measured via UV-vis spectroscopy. The amount of this complex which forms in solution is 
dependent upon the amount of ferric ions present. The more ferric ions that are present, the 
more iron thiocyanate complex forms, the more intense the UV absorbance. This therefore 
allows for the quantification of ferric ions remaining in the solution over time. 
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[𝐹𝑒(𝐻-𝑂):]+, + 𝑆𝐶𝑁. ⇌ [𝐹𝑒(𝑆𝐶𝑁)(𝐻-𝑂);]-, + 𝐻-𝑂 
Equation 5: Equilibrium of iron thiocyanate 
This is exactly what was observed over a 3-day period. Rapid diffusion into the gel was initially 
observed, before uptake began to plateau after around 120 minutes (see Figure 28). The 
concentration of ferric ions in the solution decreased from 0.1 M to 0.052 M. However, it has 
to be remembered that on addition to the gel, the effective volume of the 1 mL of solution is 
doubled to 2 mL, with the solvent in the gel. So a reduction in Fe(III) concentration by 50% 
would be fully expected based on passive partitioning of the metal ion across all the liquid-
like phase. While this is disappointing for any possible environmental applications, it does not 
signal failure for the formation of iron oxide nanoparticles within the gel. 
 
 
Figure 28: Plot of UV-Vis absorbance values of FeSCN solution over time after being introduced to DBS-CONHNH2 gel. 
Following the diffusion of ferric ions into the gel, the fate of these ions needed to be 
ascertained. The formation of nanoparticles in the gel was explored by TEM analysis, as any 
nanoparticles would be clearly visible as black dots within the gel. To prepare these gels, in 
short, ferric chloride solutions of concentrations ranging from 1.0 M to 0.005 M were 
prepared. An aliquot of each of these solutions (1 mL) was added to a separate vial containing 
1 mL of 0.4% w/v DBS-CONHNH2 gel. These were wrapped in foil and left for 48 hours before 
being submitted for TEM analysis. As a control, a sample of 1 mL alginate gel was also 
prepared and doped with iron chloride at these concentrations. A multicomponent gel was 
also formed for comparison by heating a 1 mL mixture of DBS-CONHNH2 and sodium alginate 
in a vial, allowing it to cool to form DBS-CONHNH2 gel, and then adding calcium chloride to 
gelate alginate. This multicomponent gel was then doped with ferric chloride in the same 




















UV-Vis absorbance of FeSCN at 450 nm
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Figure 29: TEM images of iron nanoparticles formed in DBS-CONHNH2 gels.  
Upper Left: Iron oxide nanoparticles formed at 0.05 M imaged at 98,000x magnification.  
Upper Right: Iron nanoclusters formed at 0.1 M at 9,300x magnification.  
Lower Left: TEM image of calcium alginate gel after being doped with iron chloride. The image shows the lack of formation 
of nanoparticles. 98,000x magnification. 
Lower right: TEM image showing formation of nanoparticles in a multicomponent gel. 68,000x magnification. 
It was observed that nanoparticles formed successfully within the gel (see Figure 29). When 
using a 0.05 M solution of ferric chloride, spherical nanoparticles of noticeable polydisperse 
size were formed while larger nanoclusters were formed at the higher concentration of 0.1 
M. In the case that nanoparticles formed successfully, it was expected that nanoclusters 
rather than nanoparticles would be more likely to form at a higher concentration. This is 
acceptable, as it shows an upper limit for concentration when forming these nanoparticles. 
The nanoparticles which were formed when using a 0.05 M solution of ferric chloride were 
likely formed by hydrolysis. The basicity of DBS-CONHNH2 has seemingly removed the need 
for a base such as ammonium hydroxide in the formation of iron oxide nanoparticles in this 
procedure. This is beneficial as it potentially removes components such as ammonium 
hydroxide from a process which aims to fabricate materials for biomedical purposes. In order 
to accurately quantify the magnetic susceptibility of these gels, magnetometry would need 
to be employed. Furthermore, the action of DBS-CONHNH2 is evidenced through the lack of 
nanoparticle formation in alginate gel. 
 
In the absence of magnetometry, magnetic properties could be predicted by determining the 
identity and oxidation state of the nanoparticles which were formed. As these nanoparticles 
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are embedded in the gel, they cannot be isolated for analysis by IR spectroscopy to find an 
iron oxide absorbance band, for example. Therefore, a more probing method which can 
detect heavy ions in an organic network was needed. X-ray photoelectron spectroscopy (XPS) 
was chosen as the ideal method to this end. Samples of ferric chloride-laden DBS-CONHNH2 
were prepared and dried under vacuum to form a dry powder for XPS analysis. 
 
XPS analysis is an excellent technique for identifying the composition of metal within the gel. 
It reveals not only the chemical composition of the material, but also the oxidation states and 
bonds between chemicals. It was reasoned this would be useful in identifying Fe-O bonds in 
the material, which will indicate the formation of iron oxide nanoparticles. This technique 
works by directing a beam of electrons in the X-ray wavelength from a source, through a 
monochromator, onto the surface of a sample. These electrons collide with electrons within 
the sample, causing the electrons within the sample to be emitted as photoelectrons. This is 
known as the photoelectric effect. The kinetic energy (KE) of this photoelectron is measured 
by the equipment. KE is determined by the incident radiation energy (h𝜐) and the binding 
energy (BE).  
 
KE	=	hυ	-	BE 
Equation 6: Photoelectric effect equation for the determination of kinetic energy of a photoelectron. 
The binding energy is dependent upon the element and orbital from which it is emitted and 
the chemical environment of the atom from which it is emitted. BE is characteristic of 
different elements in different oxidation states and chemical environments, allowing for the 
precise identification of elements present on the surface of a sample. Additionally, this 
technique is quantitative, as the number of electrons emitted at each binding energy is 
measured as intensity. An XPS plot will therefore display the number of electrons detected at 
each binding energy as sharp peaks, allowing for both qualitative and quantitative 
measurement of a sample. 
 
There are, however, a number of limitations of XPS analysis which must be considered when 
analysing the results. Firstly, this technique is not overly sensitive. Detection limits may be as 
low as 100 ppm when analysing heavy metals, becoming less sensitive with decreasing atomic 
weight.133 When working with DBS-CONHNH2 doped with ferric ions, the final concentration 
within the gel was 0.048 M, or 268 ppm. It was undesirable to increase the concentration, as 
this was shown to affect the fate of the iron nanoparticles, which would instead form large 
nanoclusters at higher concentrations. Therefore, it was hoped that increasing the total 
volume of sample by preparing a larger number of vials of DBS-CONHNH2 doped with ferric 
ions, coupled with increased measurement times, would allow for the detection of and 
analysis of iron within the gel. Secondly, there is the potential for the sample to be degraded 
by the X-ray during measurement. However, this is unlikely to affect the iron within the 
sample as it is not degraded by X-rays. The DBS-CONHNH2, however, is likely to be degraded 
by incident X-rays. Fortunately, the main focus of this experiment is the characterisation of 
iron. 
 
The XPS spectrum for ferric chloride-doped DBS-CONHNH2 (see Figure 30) revealed much 
about the nature of the nanoparticles which were formed in the gel. The formation of metal-
oxygen bonds was observed, as well as some reduced species of iron. This indicates that these 
nanoparticles may be the desired iron oxide nanoparticles. The binding energy of Cl 2p was 
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observed to be 199 e.V., which is in agreement with the value obtained for FeCl3 by Usha et 
al.,134 indicating the presence of iron-chlorine bonds within the gel, and the intensity indicates 
that this may be the dominant iron compound in the gel. However, it is also indicated that 
DBS-CONHNH2 is capable of acting as both a base and a reducing agent in this process in order 
to form iron oxide nanoparticles. This result indicates that it is possible to develop in situ 
formation of iron oxide nanoparticles to impart bulk ferromagnetic properties onto the gel 




Figure 30: XPS Spectrum of FeCl3-doped DBS-CONHNH2 
When observing the oxygen 1s region on the XPS spectrum (see Figure 31), a small peak 
characteristic of oxygen 1s in an oxygen-metal bond is observed as a shoulder on the main 
peak. While this peak is small in comparison to organic oxygen, this is likely due to the oxygen 
content of DBS-CONHNH2 being more present than the amount of oxygen present in iron 
oxide; there is far more DBS-CONHNH2 than Fe-O, therefore there will be more organic 
oxygen. Nevertheless, the presence of this peak confirms the formation of some iron oxide 
species, as no other metal was detected in the analysis. However, the intensity of this peak 
for Cl 2p is far greater than this, indicating that much more iron is present as iron chloride 


























XPS Spectrum of FeCl3-doped DBS-CONHNH2
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Figure 31: Oxygen region of the XPS spectrum for ferric chloride-doped DBS-CONHNH2. 
In the iron region of this XPS spectrum (see Figure 32), two peaks are observed for the iron 
2p orbital. Unfortunately, these peaks are similar across multiple oxidation states of iron 
making it difficult to decipher exactly in which oxidation state the iron in the sample resides. 
The intensity of the peak for the iron 2p1/2 closely matches the data reported by Radu et al.135 
for magnetite nanoparticles. Furthermore, the full-width at half-maximum (FWHM) value for 
the Fe 2p3/2 peak observed here is around 4 e.V., which is again in agreement with the FWHM 
data reported by the same group for magnetite. This indicates that iron oxide nanoparticles 
may be present within the DBS-CONHNH2 gel. The binding energies observed here also 
resemble those observed by Zhou et al.136 for Fe in FeCl2, also indicating the presence of an 
iron chloride species in the sample. XPS here has provided evidence of the presence of iron 
chloride bound to the gel, while the slight discolouration of the gel suggests some level of 
hydrolysis of iron chloride resulting in the formation of iron oxide nanoparticles 
 
 









































Fe region of the XPS spectrum for FeCl3-doped DBS-CONHNH2
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Following XPS analysis, powder x-ray diffraction (PXRD) analysis was performed on a sample 
of dried ferric chloride-doped DBS-CONHNH2. This was done in an attempt to decipher the 
phase of the iron oxide structure and complement the information provided by XPS. In this 
technique, X-rays are incident on a powder sample. Provided the sample is crystalline, the X-
ray will diffract from the sample in a characteristic pattern which can be compared against a 
database in order to determine the crystal structure. Amorphous solids, such as DBS-
CONHNH2, do not appear in PXRD diffraction patterns, and so the only observed peak should 
be that of the iron oxide nanoparticles. As X-rays interact with the surface of a crystal, some 
are diffracted and some pass through to the next layer where, again, some are diffracted and 
some pass to the next layer. This is repeated to form a diffraction pattern which is unique to 
a crystal structure. In the measurement process, the sample and the X-ray beam are both 
rotated to span different incident angles of X-rays, and the intensity of X-ray reflection from 
the sample is measured. Peaks will only be observed when there is constructive interference, 





Equation 7: Bragg's Law of X-ray diffraction. 𝜃 is the angle of incidence, 𝜆 is the x-ray wavelength, d is the crystalline 
spacing between layers. 
Briefly, the sample was prepared in the same manner as for XPS but was then dissolved in 
acetone and deposited on a sample holder. The acetone was allowed to evaporate before the 
sample was analysed. A peak was observed at 2𝜃 = 50 ° (see Figure 33), but this is likely a 
result of spectral contamination from Cu Kbeta radiation. Outside of this peak, no other peak 
was observed. This may be due to extremely low concentration of iron nanoparticles in the 
sample but may also be due to the formation of amorphous iron oxide with no crystalline 
order. The most likely explanation is concentration below the detection limit of PXRD. 
 
 
Figure 33: PXRD graph for ferric chloride-doped DBS-CONHNH2. 
In summary, there is insufficient data the in situ formation of iron oxide nanoparticles. Iron is 
incorporated into the gel and nanoparticles are formed, but the identity of these 
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nanoparticles is not fully elucidated. It is possible that there is molecular iron chloride bound 
to the gel while some iron oxide nanoparticles formed through hydrolysis. The ability of DBS-
CONHNH2 to play a role in the formation of iron oxide nanoparticles is supported by the 
formation of nanoparticles in this gel and not in calcium alginate.  
 
3.4.2 Copper Chloride and DBS-CONHNH2 
The possibility of forming nanoparticles in situ with other metals was also explored. Namely, 
copper was chosen to run as an analogue to the iron study. Copper nanoparticles have 
previously found use in antimicrobials, conductive nanoinks, and as catalysts. With these 
potential applications in mind, a similar route of investigation was embarked upon as that 
which was taken with iron, and an application was to be explored once the nature of the 
nanoparticles was elucidated. In short, 1 mL of 0.1 M cupric chloride solution was layered on 
top of 1 mL of 0.4% w/v DBS-CONHNH2 gel and left for 48 hours. The uptake of cupric ions 
was measured using UV-vis spectroscopy, and the fate of these ions within the gel was 
explored using TEM and XPS analyses. 
 
 
Figure 34: UV-vis Plot of the decrease in concentration of cupric ions in solution as determined by UV-vis spectroscopy. 
UV-vis spectroscopic analysis of the uptake of cupric ions revealed a similar pattern to that 
observed with ferric ions; a sharp uptake over the first 120 minutes followed by a plateau (see 
Figure 34). In this case, absorbance was measured at 800 nm and a decrease in the intensity 
at the absorbance maximum from 0.060 to 0.023 was observed, which equates to a decrease 
from 0.1 M to 0.038 M cupric ions in the solution when the results are plotted against a 
calibration curve. This is interesting, as it shows the formation of a concentration gradient, 
where the concentration of cupric ions is higher in the DBS-CONHNH2 than it is in the 
surrounding solution. This indicates that there is some active uptake into the gel, rather than 
just the passive diffusion observed with ferric ions. There is some affinity between cupric ions 
and DBS-CONHNH2 which was not observed with ferric ions, and this affinity may be occurring 
at the hydrazide groups on either end of the DBS-CONHNH2 molecule, perhaps complexing 
around the copper (see Figure 35) as has been observed with benzyl hydrazide groups.137 In 






















UV-Vis plot showing the decrease in concentraion of cupric 
ions in solution in the presence of DBS-CONHNH2
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Figure 35: Speculative complex of DBS-CONHNH2 and cupric ions. 
The proposed complex would form about the hydrazide group in the DBS-CONHNH2. Dative 
bonds from the primary nitrogen coordinate to the copper while keto-enol tautomerisation 
allows for bonding to the copper from the oxygen in its enolic form. This would result in the 
loss of a proton from the secondary nitrogen. DBS-CONHNH2 would act as a bidentate ligand 
on each end of the molecule, resulting in the formation of possible 2-dimensional chains of 
molecules in a manner similar to that observed in 3-dimensional metal-organic frameworks. 
It is unlikely that one molecule of DBS-CONHNH2 would bend to coordinate about a single 
cupric ion due to the significant angle strain which would be introduced in this scenario, 
making it energetically unfavourable. 
 
The formation of this complex would explain a couple of experimental observations when 
cupric ions were introduced to DBS-CONHNH2 gel. Firstly, the gel was weakened. This was not 
observed when ferric ions were used. The formation of a complex with the cupric ions would 
disrupt the supramolecular interactions within the gel. Secondly, a colour change was 
observed from blue to brown. While this may be indicative of the reduction of the cupric ions 
to metallic copper, it would also occur in the case of the formation of anhydrous cupric 
complexes – anhydrous cupric compounds are brown in colour. Additionally, evidence from 
UV-vis absorbance shows that, of the 0.1 mmol of cupric ions present in the solution, 0.062 
mmol moved into the gel. Passive diffusion would account for 0.050 mmol of this total. The 
remaining 0.012 mmol of cupric ions would have been actively taken into the gel. In 1 mL of 
0.4% w/v DBS-CONHNH2 gel, 0.008 mmol of DBS-CONHNH2 is present. According to these 
results, the complex would have a 1.5:1 Cu:DBS-CONHNH2 ratio. However, when working with 
concentrations and volumes on this scale, experimental error may lead to slight variations in 
the results and the true result may be closer to a 1:1 ratio. The experiment should, admittedly, 






































Figure 36: Brown colouration of copper chloride solution when introduced to DBS-CONHNH2 and left for 24 hours. Copper 
chloride concentrations from left to right in each image: 1.0 M, 0.5 M, 0.25 M, 0.1 M. 
The potential formation of nanoparticles was investigated by TEM (see Figure 37). 1 mL of 
0.4% w/v DBS-CONHNH2 gels were layered with copper chloride solution and left for 2 days 
before being submitted for microscopy. It was observed that nanoparticles formed in the gel 
similarly to the formation of nanoparticles when using ferric chloride. The nanoparticles here 
were homogenous in shape, all of them being spherical, and polydisperse in size. A control 
experiment was performed concurrently using 1 mL of alginate gel in place of DBS-CONHNH2, 
and a multicomponent gel was also prepared. No colour change was observed in alginate, but 
nanoparticles were observed under TEM analysis. 
 
 
Figure 37: (Left): Image of nanoparticles formed when 1 mL of 0.1 M copper chloride was introduced to 1 mL 0.4 % w/v 
DBS-CONHNH2. 49,000 x magnification 
(Middle): Nanoparticles observed in TEM imaging in copper chloride-doped alginate gel. 98,000 x magnification. 
(Right): TEM image of nanoparticles formed in copper-chloride doped multicomponent gel. 68,000 x magnification. 
The imaging of nanoparticles is promising, but it does not reveal much about the identity of 
the nanoparticles. These may be nanosized precipitate clusters of the proposed complex, or 
they may be metallic copper nanoparticles. Both scenarios are possible if the brown 
colouration of the mixture after a 48-hour period is taken into consideration. In order to 
conclusively show the oxidation state of the copper, a sample was prepared for and analysed 
via XPS in the same manner as the ferric chloride-doped DBS-CONHNH2. Analysis by XPS (see 
Figure 38) revealed that copper was present exclusively in its cupric state, therefore no 
reduction had occurred, and the nanoparticles were not metallic copper. The only metallic 
copper peak observed in the XPS spectrum was a result of X-ray reduction. However, it was 
also observed that metal-oxygen bonds were not present in the sample, with the only oxygen 
being organic oxygen. This may, however, be a result of the relatively low amount of copper 
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compared to the gelator. Any shoulder which may have been observed in the XPS spectrum 
may simply be too small to be observed. 
 
 
Figure 38: XPS Spectrum for cupric chloride-doped DBS-CONHNH2. 
The XPS results indicate that the nanoparticles formed in DBS-CONHNH2 may be copper oxide 
nanoparticles. The binding energy for Cl 2p is similar to that observed in ferric chloride-doped 
DBS-CONHNH2, indicating that metal-chlorine bonds may be present here. The formation of 
nanoparticles in both DBS-CONHNH2 and calcium alginate indicate that DBS-CONHNH2 may 
not play a specific role in the formation of these nanoparticles. As with ferric chloride-doped 
DBS-CONHNH2, the exact nature of the nanoparticles is inconclusive, with evidence pointing 
towards the formation of copper oxide nanoparticles. 
 
Before any applications could be considered, the stability of the nanoparticle-loaded gel 
needed to be assessed. To this end, rheological studies were conducted to determine to what 
extent DBS-CONHNH2 is affected and whether multicomponent gel beads can be expected to 
maintain their stiffness when cupric chloride is introduced. This would be an important step 
in determining whether using copper-loaded gels in any application is viable; if the gel does 
not retain its stiffness, then it will be useless in most applications. Therefore, it is hoped that, 
in a multicomponent gel, alginate will act to retain the stiffness of the gel while DBS-CONHNH2 
will interact with the cupric ions. This hypothesis is based upon the experimental findings that 
alginate is not destroyed by the presence of copper and that DBS-CONHNH2 was shown to 
interact in some way with the cupric ions. 
 
For the rheological studies, each sample was performed in triplicate in order to achieve 
concordant results. Therefore, each sample was prepared three times. In short, samples of 
DBS-CONHNH2 gel, calcium alginate gel, and DBS-CONHNH2 and calcium alginate 
multicomponent gel were prepared both with and without cupric chloride present. The gels 
were prepared in bottomless vials which were adjoined to a petri dish using silicone sealant, 
which is inert to the reagents present. The sealant and bottomless vial could be removed to 






















XPS Spectrum for CuCl2-doped DBS-CONHNH2
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should be accurate representations of the effect of cupric ions and not be affected by damage 
to the gel during transfer. 
 
For rheological measurements, both amplitude and frequency sweeps were performed. The 
amplitude sweep applies a range of strains to the gel in stepped amplitude and determines 
the linear viscoelastic region of the gel; that is, the range of strain which can be applied to a 
gel without destroying it. The strain is plotted along the x-axis, whilst the storage modulus 
(G’) and the loss modulus (G’’) are plotted on the y-axis. The axes are both plotted on a 
logarithmic scale. A larger storage modulus indicates that more energy is required to be input 
in order to distort the sample – simply, a stiffer gel will have a larger G’ value. In the case 
where G’ > G’’ in the linear viscoelastic region, the sample is gel-like in nature whereas if G’’ 
> G’ in the linear viscoelastic region, the sample is fluid-like. At a certain strain, a crossover 
region is observed where, in a gel-like structure, both G’ and G’’ will drop, but G’’ will become 
greater than G’ indicating the structure is destroyed above this strain. A steep drop indicates 
a brittle break, whereas a smooth drop indicates a more gradual breakdown. Based on the 
experimental observations, it was believed that DBS-CONHNH2 gel will be much less stiff once 
it has been exposed to cupric ions due to the breakdown of supramolecular interactions 
within the gel, whereas alginate gel will retain its gel-like structure because the ionic gelation 
is unaffected by the cupric ions. 
 
The determination of the linear viscoelastic region by amplitude testing also allows for a 
frequency sweep to be carried out in this region. A strain value is selected from the linear 
viscoelastic region and used for subsequent measurements. G’ and G’’ are measured at a 
constant strain as a function of frequency (S-1). A low frequency simulates minimal motion 
whereas a high frequency simulates fast motion. The more frequency dependent G’ is, the 
more fluid-like the material. As with the frequency sweep, it was expected that DBS-CONHNH2 
would behave more like a fluid after it had been doped with cupric ions. Alginate gel would 
be largely unaffected by the presence of the cupric ions. 
 
Initial rheology results indicate that DBS-CONHNH2 is a fairly weak gel with low stiffness (see 
Figure 39), in line with literature findings.118 After leaving the linear viscoelastic region, the G’ 
function displays a continuous, steady breakdown which indicates a non-brittle gel which is 
destroyed homogenously across the structure under strain. A small upturn in the values for 
G’’ after exiting the linear viscoelastic region indicates the point at which the structure begins 
to rupture, and micro cracks began to appear. Energy is lost around the micro cracks as the 
fragments are free to move and convert the deformation energy into heat energy as a result 
of the internal viscous friction. Following this upturn, the crossover region is observed where 
G’’ > G’, the point at which the structure ruptures and can be described as a viscoelastic fluid. 
It should be stated that the error bars on all rheological graphs are calculated as the standard 
error of each data point from three separate samples. 
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Figure 39: Rheology graph for DBS-CONHNH2 gel. 
From the frequency sweep (see Figure 40), it can be seen that G’ is independent of frequency 
across the range investigated, thus DBS-CONHNH2 gel is behaving as a gel. Good concordance 
of results has generated error bars of minimal size. The results for both the amplitude sweep 
and the frequency sweep for DBS-CONHNH2 were expected, and the tests were mainly 
performed as a baseline for comparison after the addition of cupric ions.  
 
 
Figure 40: Frequency Sweep for DBS-CONHNH2 Gel. 
After being doped with cupric ions, DBS-CONHNH2 is a notably weaker gel (see Figure 41), 
with G’ being much lower than in pure DBS-CONHNH2 gel. Once exiting the linear viscoelastic 
region, the breakdown here is much less steep, indicating a less brittle structure than that 
observed in the absence of cupric ions. For the frequency sweep, a new batch of samples was 
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Figure 41: Amplitude sweep for DBS-CONHNH2 doped with cupric ions. 
The frequency sweep (see Figure 42) reveals more about the nature of DBS-CONHNH2 once it 
has been doped with cupric ions. There is some frequency-dependency exhibited by the G’, 
indicating some fluid-like behaviour of the structure. This is in line with experimental 
observations that DBS-CONHNH2 is degraded to form more sludge-like structure when 
introduced to cupric ions. Furthermore, the size of the error bars indicates difficulty in 
achieving concordant results. The exact degree to which DBS-CONHNH2 is degraded by cupric 
ions appears to be inconsistent, with some samples showing complete degradation and some 
samples showing only minor degradation. Regardless, the overarching conclusion from this 
set of data is that DBS-CONHNH2 is weakened by the presence of cupric ions, indicating the 
disruption of supramolecular interactions and possibly some interaction between DBS-
CONHNH2 and these ions. 
 
 







0 0 0 1 10 100 1000
Complex Shear Strain (%)
Amplitude Sweep for DBS-CONHNH2 Doped with Cupric ions








Frequency Sweep for DBS-CONHNH2 doped with cupric 
ions
Shear modulus (elastic component)(Pa) Shear modulus (viscous component)(Pa)
 55 
Following this, the rheological properties of alginate both with and without the addition of 
cupric ions were investigated. Being a polymer gel, alginate should exhibit greater stiffness 
than DBS-CONHNH2 and should not be weakened by the presence of the cupric ions. There 
may be the potential for some ion exchange with the calcium in the gel, but the ionic character 
of the calcium-carbon bond is far greater than copper-carbon due to the differences in 
electronegativity between the two, meaning calcium-carbon bonds are likely to be stronger 
than copper-carbon bonds, resulting in ion exchange being enthalpically unfavourable.  
 
The calcium alginate gel was shown to be significantly stiffer than DBS-CONHNH2 (see Figure 
43). The same gentle break is observed once the linear viscoelastic region has been left, 
indicating that the gel is not brittle. 
 
 
Figure 43: Amplitude sweep for calcium alginate gel. 
Much like with DBS-CONHNH2 gel, the G’ is largely independent of frequency in calcium 
alginate gel, confirming that calcium alginate gel is gel-like in its rheological behaviour (see 
Figure 44). The slightly larger error bars reflect some difficulty in achieving uniform gelation 
across all three samples, but nonetheless the results are all in agreement that calcium alginate 
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Figure 44: Frequency sweep for calcium alginate gel. 
Calcium alginate gel was made slightly stiffer by the addition of these ions (see Figure 45), 
which is in line with previous studies in the Smith group involving silver ions.124 The G’ is higher 
than observed in pure calcium alginate gel, and this may be due to the copper nanoparticles 
which were observed by TEM analysis. They may be acting to increase the stiffness by forming 




Figure 45: Amplitude Sweep for Calcium Alginate gel doped with cupric ions. 
Importantly, the gel retained its frequency independent behaviour in the range tested once 
it had been doped with cupric ions (see Figure 46). This indicates that the gel retains its gel-
like structure in these conditions and no breakdown to a fluid-like state is observed. Following 
the rheological observations of both DBS-CONHNH2 and calcium alginate both with and 
without cupric ions, a multicomponent gel consisting of both DBS-CONHNH2 and calcium 
alginate was formed, and its rheological properties were investigated. It was proposed that, 
physically, the gel should behave similarly to alginate in that it will retain its stiffness in the 
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Figure 46: Frequency sweep for calcium alginate gel doped with cupric ions. 
The amplitude sweep for the multicomponent gel (see Figure 47) reveals it is similar in 
stiffness to calcium alginate gel, which is promising for the idea that the gel carries the 
physical properties of alginate gel and should therefore not be destroyed by the cupric ions. 
This rheology data is in line with results previously reported in literature.123 
 
 
Figure 47: Amplitude Sweep for multicomponent gel. 
The frequency sweep for the multicomponent gel (see Figure 48) is in agreement with the 
amplitude sweep that the gel retains the physical properties of alginate gel. This is promising, 
and further bolstered the hypothesis that the multicomponent gel should behave like alginate 
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Figure 48: Frequency sweep for multicomponent gel. 
The amplitude sweep shows that the multicomponent gel has retained its stiffness in the 
presence of cupric ions (see Figure 49) in the same nature as observed in calcium alginate gel. 
The G’ has not increased in the same manner as with calcium alginate gel, so it may be that 
the viscous component of any DBS-CONHNH2 gel which has been made less stiff by the cupric 




Figure 49: Amplitude sweep for multicomponent gel doped with cupric ions. 
The storage modulus for the multicomponent gel doped with cupric ions was independent of 
the oscillation frequency (see Figure 50). This indicates that, after addition of the cupric ions, 
the multicomponent gel retains its gel-like structure and the viscous component does not 
dominate. This is important, as it shows that a multicomponent gel with the rheological 
properties of alginate gel and the chemical characteristics of DBS-CONHNH2 is stable once it 
has been loaded with cupric ions and formed copper nanoparticles. This means that 
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Figure 50: Frequency sweep for multicomponent gel doped with cupric ions. 
 
3.4.3 CuAAC Catalysis with Copper-loaded Beads 
Ultimately, catalysis was chosen as the possible application for copper-loaded 
multicomponent gel beads. To this end, the copper(I)-catalysed azide-alkyne cycloaddition 
(CuAAC) reaction was chosen as the reaction. This is a single step click reaction which is 
biologically relevant and finds use in medicinal chemistry, for example in the synthesis of the 
𝛽-lactamase inhibitor tazobactam.138 However, common problems with using copper salts 
such as copper sulfate include inability to remove the copper from the reaction mixture and 
subsequent copper contamination of the product.  It was hypothesised that the beads could 
be added to a CuAAC reaction and catalyse the reaction without producing copper-
contaminated product. The beads could ideally be removed from the system and re-used 
multiple times before catalytic activity was reduced. It should also be noted that, despite the 
reaction being termed ‘copper(I)-catalysed’, it is far more successful when using a copper(II) 
material in the presence of a reducing agent such as sodium ascorbate to produce copper(I) 
in situ, hence it was though that Cu(II) loaded beads could be an ideal source of copper for 
this type of reaction. 
 
In this case, an adjustment of the CuAAC reaction first reported by Sharpless et al.139 was 
proposed. Sodium hydrazide was replaced with 2-azido-2-deoxy-D-glucose due to safety 
concerns, and was reacted with phenylacetylene at a 1:1 molar ratio: 
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For this reaction, multicomponent gel beads were formed on the millimetre scale. These 
beads were placed in copper chloride solution for 2 days before being washed and stored in 
water. It was noticed that the core of these beads had turned brown, while the shell remained 
light blue in colouration. This indicates that the cupric ions had precipitated as nanoparticles 
in the DBS-CONHNH2 core and were stabilised within the gel bead. It was hoped that the 
reagents would enter the bead, perform the catalysed reaction, and then be flushed out of 
the bead to yield product with minimal copper contamination.  
 
A control reaction was performed using copper sulfate solution in place of the copper-loaded 
beads to ensure the reaction did indeed proceed. No literature precedent using these exact 
reagents in a CuAAC reaction could be found, so this needed to be tested beforehand. The 
reaction was monitored by TLC analysis using a 1:1 mixture of hexane and ethyl acetate, 
imaging the phenylacetylene under UV light. Upon addition of the copper sulfate solution, 
the reaction changed from colourless to straw-yellow, indicating reduction of the copper. 
After being left to react overnight, the reaction was checked and complete consumption of 
phenylacetylene was confirmed by TLC analysis, indicating the reaction had taken place. The 
product itself, being novel, was difficult to isolate and purify. Once the product had been 
isolated as green crystals, it quickly forms a red sludge on exposure to air. It was extremely 
hygroscopic and insoluble in organic solvents. It was therefore decided that the identity of 
the product was not to be pursued, as the main focus was the catalysis of the reaction. Further 
investigation of the reaction would have been carried out. However, due to limited lab time, 
this was not conducted. Following this, the reaction was attempted in the absence of copper 
sulfate. After being allowed to react overnight, phenylacetylene was still observed in the 
reaction mixture in TLC. This confirms that, not only does the reaction proceed, but it only 
does so in the presence of a copper catalyst.  
 
Copper-loaded multicomponent gel beads were added to the reaction process in place of 
copper sulfate. All other reaction conditions were kept the same. Upon addition of the beads, 
the core changed colour from a brown to a dark orange as in the ideal reaction. Over the 
period of an hour, the reaction mixture itself began to slowly change to the orange 
colouration observed within the bead, indicating the release of copper. Promisingly, after 
being allowed to react overnight, TLC analysis confirmed the consumption of 
phenylacetylene, and a reaction had therefore occurred. However, the beads had been 
destroyed in the process and were no longer present in the reaction mixture the following 
day. This observation would explain the release of copper into the reaction mixture. 
 
In order to investigate the breakdown of the beads, a set of multicomponent gel beads were 
stirred in a 1:1 v/v mixture of water and tert-butanol overnight. It was not believed that the 
stirring action would destroy the beads, as alginate is a relatively stiff polymer gel and 
therefore resistant to destruction by physical means of the same strength as being stirred in 
solution. It was noticed that the beads were destroyed in this test, indicating that tert-butanol 
is causing the destruction of the beads. This was removed from the next attempt at the CuAAC 
reaction, which was performed in entirely aqueous conditions. This should not be a problem 
for the reaction itself, as reagents which are partially insoluble will be gradually dissolved as 
they are reacted to form product. Unfortunately, it was again noticed that the beads were 
destroyed in the reaction. 
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In a follow-up investigation, the beads were stirred in water with the reducing agent sodium-
L-ascorbate. Here, it was noticed that the beads were destroyed. It is likely that sodium-L-
ascorbate is scavenging calcium ions from the alginate gel, causing the ionic gelation model 
to breakdown and ultimately destroy the gel. This was a frustrating discovery, as many other 
reducing agents would likely interact with DBS-CONHNH2, meaning there was little recourse 
to salvage this specific experiment. One manner in which this problem could be solved would 
be to use a different polymer gel which is not affected by sodium-L-ascorbate and would 
therefore be able to survive the experiment.  
 
Nonetheless, this line of investigation has yielded some useful insights. Copper(II)-loaded 
multicomponent gel beads in which the supramolecular gel has formed nanoparticles have 
successfully been fabricated. These beads have been shown by rheological studies to possess 
the stiffness of calcium alginate, meaning they have the potential to be added to reactions 
and subsequently removed, washed, and reused. A lot more work could be done to optimise 
the use of Cu(II)-loaded hybrid hydrogel beads in click chemistry. Changing the polymer 
gelator to one such as agarose may prevent destruction of the beads. While a successful path 
may not be forged using cupric ions, other ions such as cobalt(II), nickel(II), or silver(II) may 
yield far greater results.  
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4. Conclusions and Further Work 
Overall, the project may be described as a moderate success which still needs work in order 
to reach definite conclusions. Multicomponent gel beads were successful fabricated in sizes 
significantly smaller than prior to the project, and the controlling factor – the viscosity of the 
oil phase – was identified. This result alone is enough to state there is some success in the 
project, the correlation between oil-phase viscosity and bead size will allow for the fabrication 
of beads of specific sizes in future for different applications; beads between 200 – 1000 nm 
may find use in oral drug delivery. It must, of course, be remembered that this is just the 
beginning of the project, and that much work is still required before it can be concluded.  
 
With the metal-doped gels, interesting observations were made, but no successful route of 
investigation was found. When copper was used, metal nanoparticles containing cupric ions 
were formed, but no application was found for these. Their use as catalysts in a CuAAC 
reaction was explored, but the multicomponent gel bead in which they were encapsulated 
was destroyed during the experiment due to the action of the reducing agent. The gels which 
contained iron were found to form iron oxide species, but a majority of the iron remained as 
molecular iron chloride bound to the gel, as shown by XPS. 
 
There is clear scope for substantial further development of the methodology and application 
of multicomponent gel beads. Relatively, this work is still in its infancy; low yields of product 
and inability to produce electron microscopy images have hampered the progression of this 
work. There are possible solutions to this, which may potentially lead to further studies in 
uptake and release of pharmaceutical agents, and subsequent studies into the efficacy of the 
beads. 
 
Initially, yields may be improved through greater centrifugation of the mixture obtained in 
the fabrication process. Unfortunately, the centrifuge available would not achieve rotation 
rates greater than 3990 rpm. By applying Stokes’ Law of centrifugation, this would apply a 
gravitational force of 2580.81 m s-2 to the particles in the centrifuge tube. Spherical particles 
of 200 nm in diameter would reach of velocity of 2.84 nm s-1 in the medium used in this 
process. This means that, theoretically, the sample needs to be centrifuged for 4702.55 
minutes – or 3.27 days – in order to achieve complete sedimentation of all particles 200 nm 
in diameter. If the rotation rate were increased to 15,000 rpm, this would be reduced to 5.55 
hours. While not ideal, this is a drastic improvement on the current method. Furthermore, 
this would only be necessary if a 100 % yield is absolutely required; less time may be taken if 
a lower yield is acceptable. Further purification methods could also be explored, such as 
dialysis. 
 
The main barrier to imaging the beads was the type of filter available for electron microscopy. 
The lowest size filter available was 400 nm, meaning that any beads with a lower diameter 
than this were simply lost in the washing process. Any methods which required the drying of 
the beads prior to imaging resulted in aggregation of the beads and a large mass of gel being 
observed. An ideal solution would be to use filters with pore sizes lower than the desired bead 
size, retaining the beads for imaging. Another possible solution may be to use atomic force 
microscopy (AFM) to image the beads in liquid medium. Successful imaging of the nanosized 
beads is essential evidence for the furthering of this project. This process would also need to 
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be conducted with the iron oxide nanoparticle-containing beads, to provide proof that the 
beads themselves contain magnetic nanoparticles. 
 
Following this, the core-shell nature of the beads needs to be proven. On a larger (millimetre) 
scale, this can be shown by cutting a bead in half and observing an interface between the 
alginate shell and the DBS-CONHNH2 core. On the nanometre scale, this is simply not possible. 
One way in which the core-shell nature may be shown would be through small-angle neutron 
scattering (SANS). This may possibly work by using a deuterated solution of calcium chloride 
when triggering the gelation of alginate, which would hopefully result in a deuterated shell. 
This would create contrast between the core and the shell when probing the structure with 
SANS, allowing for differentiation between the two.  
 
Upon improving the yield and confirming the structure of the beads, the core:shell ratio 
should be confirmed. This should be done via elemental analysis in order to ascertain the 
amount of both alginate and DBS-CONHNH2 in the bead. From this, the thickness of the shell 
could be calculated and tuned in subsequent fabrication methods by either using more or less 
alginate to induce a thicker or thinner shell, respectively. This may help to tune the physical 
properties of the bead. A thicker shell, for example, would likely result in greater stiffness and 
improved longevity of the beads but possibly at the loss of some drug loading into the DBS-
CONHNH2 core in a drug delivery scenario. 
 
The magnetic properties of beads containing iron oxide nanoparticles would need to be 
determined. Ideally, a portion of a sample would be imaged to show iron oxide nanoparticles 
are embedded in the beads rather than in suspension around the beads. Following this, 
magnetometry measurements would be conducted to ascertain the magnetic susceptibility 
of the beads. This would be important for future applications such as targeted drug delivery, 
as knowing the magnetic susceptibility would allow for the determination of a minimum 
required strength of an applied magnetic field to induce movement in the beads.  
 
Possible applications of the multicomponent gel beads would also be explored in future work. 
Chiefly, the ability of the beads to act as drug delivery vehicles would be explored with the 
use of an anti-cancer agent. The choice of drug would rely heavily on its hydrophilicity, with 
more hydrophilic drugs being favourable as they would be easier to load into the beads in the 
reverse-emulsion method. One possible drug which may be used for this investigation would 
be gemcitabine, a hydrophilic and low-cost anti-cancer agent used in the treatment of a wide 
range of carcinomas. Uptake and release studies would need to be conducted in order to 
ascertain the effectiveness of the beads as a drug delivery vehicle for this specific drug, as 
well as rheological studies to determine the effects gemcitabine would have on the gels at 
various concentrations. Once drug-loaded beads have been fabricated, in vitro studies would 
need to be conducted to study the cytotoxicity of the beads, before possible in vivo studies. 
 
Once this has been done using non-magnetic beads as a ‘proof-of-concept’, iron oxide 
nanoparticles will be introduced to the procedure. Ideally, this would fabricate nanosized 
multicomponent gel beads containing magnetic nanoparticles and an anti-cancer drug. DLS, 
electron microscopy, rheology, and UV-vis measurements would be taken to determine the 
size, structure, stiffness, and drug loading, respectively, of the beads. After this, in vitro 
studies would be conducted to determine whether a magnetic field of suitable strength can 
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direct the nanosized beads through tissue to a target area. This would ideally reduce off-
target effects by concentrating the release of the drug at a target area, or at least increasing 
the rate at which the beads reach a target area. By applying an alternating magnetic field to 
the beads, magnetic hyperthermia should be observed, raising the temperature around the 
target site to around 46℃ resulting in cell death. Concurrently, this increase in temperature 
may lower the stiffness of the DBS-CONHNH2, releasing the anti-cancer agent at a higher rate 
than at a lower temperature. Summarily, this would hopefully result in a dual-action drug-
delivery vehicle capable of targeted delivery, which is biocompatible and relatively simplistic 
to fabricate. 
 
As a possible alternative project, the interaction between DBS-CONHNH2 and metal salts 
could be studied further. The ability of copper-laden multicomponent gel beads to catalyse 
reactions such as the CuAAC reaction could be further investigated by using a polymer gel 
other than alginate, such as agarose. Ideally, these beads would not be destroyed by the 
presence of the reducing agent, and the reaction would proceed with minimal copper 
contamination of the product. However, as DBS-CONHNH2 proved unable to reduce copper 
to its cuprous state, its presence in this system may be superfluous. If the catalytic ability of 
the copper nanoparticles formed by the gel is greater than a system using free solutions of 
copper, then DBS-CONHNH2 would indeed be useful in this reaction, as it would concurrently 
reduce copper contamination and increase catalytic ability.  
 
Overall, this project has opened up myriad possibilities for further investigation. DBS-
CONHNH2 is a versatile gelator which may have a future in biomedical research for drug 
delivery, or in catalysis chemistry owing to its interactions with metallic ions. There is, of 




5. Experimental Section 
Dynamic light scattering (DLS) experiments were performed on a Malvern Zetasizer Nano 
Series from Malvern Instruments Ltd., UK, and results were processed using the Zetasizer 
software application V. 7.01. Sample measurements were performed at 25 ℃ using back-
scattered light fluctuations at 173 °. Measurements were performed in triplicate, with 
sonication of the sample between measurements to counteract sedimentation. 13 runs were 
performed with each measurement and the mean values were calculated and graphed by the 
software. All bead samples were measured in water. When filtering, a 450 nm nylon filter was 
used. 
 
UV-Vis measurements were performed using a Shimadzu UV-2401PC spectrophotometer 
with Standard Personal Spectroscopy Software installed. Samples were presented in a glass 
cuvette.  
 
1H NMR experiments were conducted using a JEOL JNM-ECS400a at a frequency of 400 MHz 
spectrometer and data was analysed using MestReNova software version 14.1.0-24037. 
Samples were presented in a Norrell S400 NMR tube.  
 
Rheology was conducted using a Malvern Instruments Kinexus Pro+ rheometer from Malvern 
Panalytical. All measurements were performed at 25 ℃. 
 
Samples for electron microscopy were submitted to the microscopy service in the 
Department of Biology at the University of York. TEM was performed using a FEI Tecnai 12 G2 
equipped with CCD camera. SEM was performed using a JEOL JSM-6490LV electron 
microscope.  
 
Samples for x-ray photoelectron spectroscopy were submitted to the XPS analysis service in 
the Cardiff Catalysis Institute at the University of Cardiff and analysed by a Shimadzu Kratos 
Axis Ultra-DLD.  
 
Synthetic procedures were carried out without further purification of the materials used. 
 
5.1 Synthesis of DBS-CONHNH2 
Synthesis of DBS-CO2Me. D-Sorbitol (5.103 g, 28.01 mmol) was added to a cyclohexane (70 
mL) and methanol (40 mL) mixture under stirring at 50 °C. 4-methylcarboxybenzaldehyde 
(7.497 g, 45.60 mmol) and p-Toluenesulfonic acid (p-TsOH) (1.037 g, 6.022 mmol) were added 
to methanol (50 mL) and stirred until complete dissolution was observed. This solution was 
then added dropwise to the D-Sorbitol solution under Dean-Stark conditions. Following 
complete addition, the temperature was raised to 70 °C and left for 2 hours. The product, a 
white paste, was filtered under vacuum and washed with ice cold methanol (2 x 60 mL), 
boiling water (3 x 100 mL), and dichloromethane (3 x 100 mL) before being dried and 
collected. Yield: 28% (3.552 g, 7.60 mmol). 1H NMR (400 MHz, DMSO-d6): 𝛿 7.98-7.92 (m, 4H, 
aromatic H), 7.63-7.54 (m, 4H, aromatic H), 5.73 (s, 2H, aromatic CH), 4.93 (d, 1H, CHOH), 4.47 
(br, 1H, CH2OH), 4.23-4.14 (q, 3H, sugar (overlap)), 3.98 (s, 1H, sugar), 3.86 (d, 1H, sugar), 3.81 
(s, 6H, OCH3), 3.75 (br, 1H, sugar), 3.61-3.58 (m, 1H, sugar), 3.51-3.48 (m, 1H, sugar). ESI-MS 
(m/z) calculated for C24H26O10 474.152, found 475.160 (100% [M+H]+). 𝜐max (cm-1): 2956, 
1724, 1435, 1399, 1276, 1167, 1094, 1018, 856, 835, 750, 709. 
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Synthesis of DBS-CONHNH2. DBS CO2Me (1.125 g, 2.373 mmol) was dissolved in THF (50 mL) 
followed by the addition of hydrazine monohydrate (8 mL, 164.9 mmol). This mixture was 
heated to 70 °C under reflux and allowed to react overnight. The resulting white paste was 
filtered under vacuum and washed with water (5 x 80 mL) before being dried and collected 
as a white powder. Yield: 64% (0.720 g, 1.52 mmol). 1H NMR (400 MHz, DMSO-d6): 𝛿 9.77 (s, 
2H, CONHNH2), 7.80-7.77 (m, 4H, aromatic H), 7.50-7.46 (m, 4H, aromatic H), 5.68 (s, 2H, 
aromatic CH), 4.90-4.88 (d, 1H, CHOH), 4.45 (s, 2H, CONHNH2), 4.45-4.41 (t, 1H, CH2OH), 4.20-
4.12 (q, 1H, sugar), 4.14 (s, 1H, sugar), 3.95 (s, 1H, sugar), 3.85-3.82 (d, 1H, sugar), 3.75-3.70 
(m, 1H, sugar), 3.61-3.56 (m, 1H, sugar), 3.45-3.40 (m, 1H, sugar). ESI-MS (m/z) calculated for 
C22H27N4O8 474.18, found 475.18 (100% [M+H]+). 𝜐max (cm-1): 3293, 2869, 1634, 1569, 1093. 
 
5.2 Synthesis of Iron Oxide Nanoparticles 
Ferrous chloride tetrahydrate (1.51 g, 7.6 mmol) and ferric chloride (3.02 g, 18.6 mmol) were 
added to distilled water (100 mL) and stirred under nitrogen for 3 hours at room temperature. 
Sodium n-dodecyl sulfate (0.226 g, 0.78 mmol) was dissolved in ammonium hydroxide (10 mL, 
35%) by stirring vigorously for 1 hour. This solution was injected via syringe into the iron 
solution to immediately yield a black precipitate. The product was filtered under vacuum and 
washed with distilled water (5 x 50 mL) before being dried under vacuum and collected. Yield 
97% (1.721 g, 7.4 mmol). 
 
A 1mg/mL suspension of nanoparticles was produced by adding iron oxide (5 mg) to water (5 
mL) and sonicating for 1 hour. 
 
When poly(ethylene glycol) was used as the capping agent, ferrous chloride tetrahydrate 
(1.504 g, 7.565 mmol) and anhydrous ferric chloride (3.024 g, 18.64 mmol) were added to 
water (100 mL) and stirred under nitrogen at 60 ℃ for 4 hours. Poly(ethylene glycol) (0.094 
g, 0.012 mmol) was dissolved in water (10 mL) before being injected into the hot solution. 
This was followed by injecting ammonium hydroxide (10 mL, 35%, 87.90 mmol) into the 
solution. The product was filtered under vacuum and washed with water (5 x 100 mL) before 
being allowed to air dry overnight. It was then washed with ethanol (200 mL) before being 
dried under vacuum and collected. Yield 97% (1.701 g, 7.347 mmol). 
 
5.3 Fabrication of DBS-CONHNH2/Alginate Multicomponent Gel Beads 
5.3.1 Fabrication in Paraffin Oil 
DBS-CONHNH2 (3.00 mg, 0.006 mmol) was added to water (0.5 mL) and sonicated to form a 
uniform suspension. To this suspension, sodium alginate solution (1% wt/vol, 0.5 mL) was 
added, and the mixture was heated using a heat gun to form a colourless, transparent 
solution. This solution was dropped (20 μL/drop) over a 2-minute period into paraffin oil (40 
mL) and Span80 non-ionic surfactant (0.8 mL) under vigorous stirring. This mixture was 
allowed to stir for 1 hour. Calcium chloride (5% wt/vol, 1 mL) was then dropped into the 
mixture to initiate the gelation of alginate and allowed to stir for a further 20 minutes. The 
mixture was centrifuged at 3990 rpm for 5 minutes, with the supernatant being discarded 
afterwards. This was repeated 3 times using petroleum ether, 3 times using ethanol, and 3 




The beads were characterised using DLS analysis, IR spectroscopy, and 1H NMR spectroscopy 
and imaged using electron microscopy. 
 
When investigating the effect of the volume of the oil phase, the volume was increased to 
200 mL of paraffin oil and 4 mL of Span80. The volume of gelator used was kept constant. 
Centrifugation in this case was repeated until the entirety of the paraffin oil had been 
centrifuged (10 times) before the regular washing procedure was conducted. 
 
When the effect of temperature on the formation of the beads was investigated, paraffin oil 
(40 mL) was heated to 95 ℃ before the aforementioned method was carried out. The mixture 
was allowed to cool to room temperature after the 20-minute stirring step before 
centrifugation. 
 
When investigating whether sonication induces the formation of smaller beads, the use of a 
magnetic stirrer was replaced with a sonic bath. All other parameters were kept constant. 
 
5.3.2 Fabrication in lower viscosity oil phases 
DBS-CONHNH2 (3.00 mg, 0.006 mmol) was added to water (0.5 mL) and sonicated to form a 
uniform suspension. To this suspension, sodium alginate solution (1% wt/vol, 0.5 mL) was 
added, and the mixture was heated using a heat gun to form a colourless, transparent 
solution. This solution was dropped (20 μL/drop) over a 2-minute period into a mixture 
containing the oil phase (either ethyl acetate, n-butyl acetate, amyl acetate, heptane, or 
hexane, 40 mL) and the non-ionic surfactant Span80 (0.8 mL) under vigorous stirring using a 
cross-stirrer bar. To this mixture, glycerol (1 mL) was added and stirred for 10 minutes. 
Calcium chloride 5% wt/vol, 1 mL) was then dropped into the mixture to initiate the gelation 
of alginate and allowed to stir for a further 5 minutes. After being removed from the stirrer, 
the mixture was transferred to a separating funnel, and the glycerol layer was collected while 
the oil phase was discarded. The glycerol layer was transferred to a centrifuge tube and 
diluted to 10 mL with ethanol. The mixture was centrifuged at 3990 rpm for 10 minutes. The 
supernatant was discarded, and the centrifugation was repeated with ethanol twice more, 
and then three times with distilled water. After the final wash, the sample was stored in 
distilled water (1 mL) and sonicated for 30 minutes. 
 
5.4 Metal ion uptake study  
5.4.1 Ferric chloride  
Ferric chloride (0.1640 g) was dissolved in water (10 mL) to form a 0.1 M stock solution which 
was stored in a sealed container. 
 
Potassium thiocyanate (0.0973 g) was dissolved in water (10 mL) to form a 0.1 M stock 
solution.  
 
A series of dilutions of ferric chloride (0.05 mL) of 0.1 M, 0.05 M, 0.025 M, 0.0125 M, and 0.0 
M was prepared, to which an equal volume of equal concentration potassium thiocyanate 
was added. This blood-red complex was diluted to 2 mL and the absorbance at 450 nm was 
measured using a UV-vis spectrometer.  
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DBS-CONHNH2 (4.00 mg, 0.008 mmol) was suspended in water (1 mL) and heated to form a 
colourless solution. This solution was allowed to cool to form a colourless gel. Ferric chloride 
solution (0.1 M, 1 mL) was gently layered on top of the gel. An aliquot of the solution (0.05 
mL) was taken at regular time intervals and complexed with potassium thiocyanate (0.1 M, 
0.05 mL) before being diluted to 2 mL with water. The absorbance of the solution was 
measured at 450 nm.  
 
5.4.2 Cupric chloride  
Cupric chloride (0.1340 g) was dissolved in water (10 mL) to form a 0.1 M stock solution.  
 
A series of dilutions of cupric chloride (0.1 mL) of 0.1 M, 0.05 M, 0.025 M, 0.0125 M, and 0.0 
M was prepared. These were diluted to 2 mL and the absorbance at 800 nm was measured.  
 
DBS-CONHNH2 (4.00 mg, 0.008 mmol) was suspended in water (1 mL) and heated to form a 
colourless solution. This solution was allowed to cool to form a colourless gel. Cupric chloride 
(0.1 M, 1 mL) was gently layered on top of the gel. An aliquot of the solution (0.1 mL) was 
taken at regular time intervals and diluted to 2 mL with water. The absorbance of the solution 
was measured at 800 nm.  
 
5.5 Formation of metal nanoparticles in gels.  
Ferric chloride (1.625 g) was dissolved in water (10 mL) to form a 1.0 M stock solution.  
 
Cupric chloride (1.352 g) was dissolved in water (10 mL) to form a 1.0 M stock solution.  
 
DBS-CONHNH2 (4.00 mg, 0.008 mmol) was suspended in water (1 mL) and heated to form a 
colourless solution, which was then allowed to cool and form a gel. This was repeated 16 
more times to produce a total of 17 individual vials of 0.4% wt/vol DBS-CONHNH2 gel. The first 
of these served as a control. To 8 of these vials, ferric chloride solution (1 mL) of a series of 
concentrations (1.0 M, 0.5 M, 0.25 M, 0.1 M, 0.05 M, 0.025 M, 0.0125 M, and 0.005 M) was 
added. The vials were covered in foil and left for 48 hours. This was repeated with the 
remaining 8 vials using cupric chloride.  
 
The most distinct colour change was observed in the 0.1 M and 0.05 M solutions of cupric 
chloride thus these were chosen as the most hopeful candidates in both series of metals for 
viewing under SEM and TEM. Excess liquid was removed using a glass pipette and the samples 
were submitted for electron microscopy with no further modification. 
 
Calcium alginate gels were formed using sodium alginate (1%, 0.8 mL) and water (0.2 mL). To 
this, calcium chloride (5%, 1 mL) was added. After gelation, excess liquid was removed and 
replaced with either cupric chloride (0.1 M or 0.05 M, 1 mL) or ferric chloride (0.1 M or 0.05 
M, 1 mL). These samples were left for 3 days before excess liquid was removed and the 
samples were submitted for SEM and TEM. 
 
Multicomponent gels were formed using a both DBS-CONHNH2 and alginate. For these gels, 
DBS-CONHNH2 (3.00 mg, 0.006 mmol) was added to water (0.5 mL) and sonicated to form a 
uniform suspension. Sodium alginate (0.5 mL) was then added, and the mixture was heated 
using a heat gun before being allowed to cool and gelate. Calcium chloride (5%, 1 mL) was 
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then added. After one day, excess liquid was removed and replaced with either cupric 
chloride (0.1 M or 0.05 M, 1 mL) or ferric chloride (0.1 M or 0.05 M, 1 mL). These samples 
were left for 3 days before excess liquid was removed and the samples were submitted for 
SEM and TEM. 
 
Twelve vials of DBS-CONHNH2 gel (0.4% wt/vol, 1 mL) were prepared. To six of these, ferric 
chloride (0.1 M, 1 mL) was added. To the other six, cupric chloride (0.1 M, 1 mL) was added. 
These were wrapped in foil and left for 2 days before being dried under vacuum and collected 
for XPS analysis.  
 
5.7 Preparation of Gels for Rheology 
DBS-CONHNH2, calcium alginate, and multicomponent gels were prepared in triplicate in 6 
mL bottomless vials. The vials were sealed onto petri dishes using silicone sealant to prevent 
leakage before gel formation. 
 
Nine vials of DBS-CONHNH2 gel were formed through the previously described method. Three 
of these were left unaltered before rheology measurements were obtained. To the other six, 
cupric chloride (0.1 M, 1 mL) was added, and the vials were left for 2 days before rheology. 
 
Nine vials of calcium alginate gel were formed by adding calcium chloride (5%, 1 mL) to 
sodium alginate (1%, 0.8 mL) and water (0.2 mL). These nine were separated and treated in 
the same manner as the DBS-CONHNH2. 
 
Nine vials of multicomponent gels were formed with DBS-CONHNH2 (3.00 mg, 0.006 mmol) 
in water (0.5 mL). This suspension was sonicated before sodium alginate (1%, 0.5 mL) was 
added. This solution was heated and allowed to cool before calcium chloride (5%, 1 mL) was 
added. These nine vials were treated in the same manner as the previous two sets of gels. 
 
5.8 CuAAC Reaction 
A stock solution of sodium ascorbate (1 M) was produced by adding sodium-L-ascorbate 
(198.37 mg, 1.00 mmol) to water (1 mL). The solution was stored in a sealed vessel and was 
replaced every two days. 
 
A stock solution of copper sulfate (0.3 M) was produced by dissolving anhydrous copper 
sulfate (48.76 mg, 0.306 mmol) to water (1 mL) and sonicating for 5 minutes to ensure 
complete dissolution. 
 
Copper-doped multicomponent gel beads were formed by adding DBS-CONHNH2 (3.00 mg, 
0.006 mmol) to water (0.5 mL) and sonicating to form a homogenous suspension. To this, 
sodium alginate (1%, 0.5 mL) was added. The mixture was heated and added dropwise while 
hot into calcium chloride (5%). These millimetre-sized beads were washed in distilled water 
before being added to a cupric chloride solution (0.1 M, 4 mL) and stored for 2 days. Following 
this, the beads were stored in distilled water until used.  
 
Copper-doped alginate beads were formed by adding sodium alginate (1%, 1 mL) dropwise 
into calcium chloride (5%). These beads were washed in distilled water before being added 
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to a cupric chloride solution (0.1 M, 4 mL) and stored for 2 days. Following this, the beads 
were transferred to distilled water where they were kept until they were used. 
 
In a set up for a control reaction, 2-azido-2-deoxy-D-glucose (20.39 mg, 0.01 mmol) and 
phenylacetylene (10 𝜇L, 0.01 mmol) were added to water and tert-butanol (10 mL, 1:1) under 
stirring. Sodium ascorbate solution (1 M, 300 𝜇L) was added, followed by copper sulfate 
solution (0.3 M, 100 𝜇L). The reaction was stirred overnight without heating. TLC analysis was 
performed the following morning using a 1:1 mixture of hexane and ethyl acetate. The 
reaction mixture was diluted with water (50 mL) and cooled in an ice bath for 2 hours. The 
solution was then concentrated using a Rotavap rotary evaporator to afford crude product 
(29.01 mg, 98%). 
 
A reaction using multicomponent gel beads was carried out by adding 2-azido-2-deoxy-D-
glucose (20.22 mg, 0.01 mmol) and phenylacetylene (10 𝜇L, 0.01 mmol) to a mixture of water 
and tert-butanol (10 mL, 1:1) under stirring. Sodium ascorbate solution (1 M, 300 𝜇L) was 
added, followed by 10 millimetre-sized copper-doped multicomponent gel beads (c. 1 mL). 
The reaction was stirred overnight without heating. TLC analysis was performed the following 
morning using a 1:1 mixture of hexane and ethyl acetate. The reaction mixture was diluted 
with water (50 mL) and cooled in an ice bath for 2 hours. The solution was then concentrated 
using a Rotavap rotary evaporator to afford crude product (28.61 mg, 97%).  
 
This reaction was repeated using copper-doped alginate gel beads in place of the 
multicomponent gel beads. 
 
The effect of tert-butanol on the gel beads was investigated by adding 10 multicomponent 
gel beads to a mixture of water and tert-butanol (10 mL, 1:1) and stirring overnight. A second 
reaction vessel was set up with the same reagents but was not stirred. 
 
For the reactions in water, 2-azido-2-deoxy-D-glucose (20.00 mg, 0.01 mmol) and 
phenylacetylene (10 𝜇L, 0.01 mmol) were added to water (10 mL) under stirring. This reaction 
was set up in two reaction vessels. To one flask, sodium ascorbate solution (1 M, 300 𝜇L) and 
copper sulfate solution (0.3 M, 100 𝜇L) were added. To the other, sodium ascorbate solution 
(1 M, 300 𝜇L) and 10 millimetre-sized copper-doped beads (c. 1 mL) were added. The reaction 
was allowed to stir overnight. TLC analysis was performed before the reaction mixture was 
diluted in water (50 mL) and cooled in an ice bath. 
 
The effect of sodium ascorbate on the beads was investigated by stirring 10 multicomponent 
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Appendix 1: Proton NMR spectrum of DBS-CO2Me. 'A' shows the full spectrum, 'B' shows a 






















Appendix 2: Proton NMR spectrum of DBS-CONHNH2. 'A' depicts the entire spectrum, while 'B' depicts the aromatic and 
amine region, and 'C' depicts the complex sugar backbone region. 
